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“There are no secrets to success. It is the result of preparation, hard 
work, and learning from failure" 
Colin Powell
 V  
 
 
Preface 
The first brick for this PhD study was laid already the day that I was hired for my 
current position as an orthopedic staff-specialist. My future clinical chief, the future 
main supervisor of this PhD, asked me if I would be willing to do a “small project” 
once hired for my new position. What does one say when asked such a question at the 
job interview?  
The journey of arriving at the point of submission of this PhD thesis has been a true 
adventure, one of dedication and challenges. Long dark hours in solitude at the X-ray 
lab and wandering the hallways of the surgical department at nighttime and on 
weekends in order to obtain radiographic exposures to my “family” of 
anthropomorphic phantoms. The fantastic experience of international collaboration in 
France. Learning by doing; project management, handling sophisticated x-ray 
equipment as well as keeping up with deadlines and performance goals. 
In the course of this study, I have come to truly understand the importance of 
collaboration, both internal as well as external. The importance of the resulting 
domestic and international network is priceless. Science is the result of teamwork and 
the presented work could not have been effectuated had it not been for the 
collaboration of, and help from numerous people. 
The work on which this PhD thesis is based was conducted over the years 2016-2019 
while employed part-time as an orthopedic staff-specialist at the University Hospital 
of Aalborg, and enrolled part-time as a PhD student at the Department of Clinical 
Medicine, Aalborg University. 
The experimental work was carried out at the following institutions: 
Department of Orthopedic Surgery, Aalborg University Hospital, Denmark. 
University College Nordjylland (Radiografskolen), Aalborg, Denmark. Institut de 
Biomécanique Humaine Georges Charpak, Paris, France. Department of Pediatric 
Orthopedics, and the Department of Radiology at Armand Trousseau Hospital, 
Sorbonne Université, APHP Paris, France. 
The studies  for this PhD are in continuation of the work initiated and conducted by 
Petersen and Eiskjær in 2012 on radiation dose optimization during assessment and 
treatment of spinal pathologies. 
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Thesis at Glance  
 
PAPER I 
 
Aims: To report absorbed organ dose and effective dose using the new EOS imaging 
micro-dose scan protocol for full-spine imaging. Secondly, to compare these 
measurements to EOS standard-dose protocol and convention digital radiology (CR). 
Design: A comparative study exploring radiation dose exposure measured in 
anthropomorphic dosimetry phantoms. 
Primary outcome: A 5 to 17-fold reduction in radiation dose when using micro-dose 
protocol compared with standard-dose protocol and CR. 
Conclusions: Full-spine imaging with EOS micro-dose protocol yields less radiation 
dose exposure than other currently available x-ray modalities. Measurements were 
reliable and comparable to literature. 
PAPER II 
 
Aim: To clinically validate a dose-optimized reduced micro-dose protocol for 3D 
reconstruction of the spine.  
Design: A prospective study on clinical validation of a reduced micro-dose protocol 
for 3D reconstruction of the spine developed from semi-quantitative 
anthropomorphic phantom image analysis. 
Primary Outcome: Clinical validation of the reduced micro-dose protocol for 
acceptable 3D reconstruction of the spine. 
Conclusion: The reduced micro-dose protocol provided reproducible 3D 
reconstruction of the spine and allowed for screening and radiographic follow-up of 
pediatric patients with low to moderate degrees of scoliosis. The reduced micro-dose 
protocol could replace the micro-dose protocol in such patients. Standard-dose 
protocol remains superior to both reduced micro-dose protocol and regular micro-
dose protocol.  
PAPER III 
 
Aim: To clinically validate a new ultra-low-dose protocol for reliable  2D Cobb 
angle measurements. 
Design: A prospective clinical validation study. 
Primary Outcome: An ultra-low-dose protocol (the “nano-dose” protocol) was 
established and subsequently clinically validated for reliable 2D Cobb angle 
measurements. Variability was <5° from the mean using 95% confidence intervals. 
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Conclusion: The proposal to use this clinically validated nano-dose protocol for 
routine radiographic follow-up of scoliotic pediatric patients, reducing radiation 
dose to a minimum while still obtaining reliable measurements of Cobb angles. 
PAPER IV 
 
Aim: To evaluate type and frequency of radiographic imaging and total cumulative 
radiation exposure to patients treated for scoliosis. 
Design: A single center retrospective review study, and a survey study on trends of 
management and radiological follow-up algorithms for scoliotic patients between 
international spine centers.   
Primary Outcomes: Surgically treated patients with scoliosis received a median 
dose of cumulative radiation dose 10-fold higher than conservatively treated 
patients. A substantial variability was found for radiographic follow-up protocols 
among eight international spine-centers.  
Conclusion: The full-body absorbed radiation dose for surgically treated scoliotic  
patients varies greatly as a result of different radiographic follow-up protocols and 
the use of intraoperative CT based navigation. It is possible to keep dose rates low 
when applying new low-dose stereography and low-dose protocols for intraoperative 
navigation, and still provide state of the art treatment for scoliosis. 
PAPER V 
 
Aim: To evaluate different variables influencing measurements of radiation dose 
absorption in the liver and to evaluate the minimum of TLDs needed to accurately 
measure absorbed radiation dose to the liver. 
Design: A methodological study evaluating the number of dosimeters and the 
location of these needed to ensure acceptable accuracy of organ dose measurements 
for the liver in the anthropomorphic ATOM phantom. 
Primary outcome: Results using generalized linear mixed effects model analysis 
and subset analysis showed that TLD position, rotation of the phantom and the 
specific TLD tablet influenced radiation dose measurements. Four to six TLDs out 
of 28 could ensure an accurate measurement of absorbed liver dose.   
Conclusion: It is possible to reduce the time spent on organ dosimetry by more than 
75%, in the case of the liver, and still get valid mean organ dose results, lying within 
95% CI of “true” mean organ dose values based on all 28 dosimeter locations. 
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Abbreviations 
AIS  Adolescent Idiopathic Scoliosis 
ALARA  As Low As Reasonable Achievable 
AP  Anterior-Posterior  
APL  Anterior-Posterior-Lateral 
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English Summary 
Radiographic imaging is the second most significant cause of ionizing radiation. The 
use of medically induced ionizing radiation, especially Computed Tomography (CT) 
has been on the rise for the past many decades. The Atom bomb survivor studies have 
shown that the risk of adverse health effects such as radiation induced cancer is 
proportional to the amount of radiation dose absorbed to the human body. Studies 
from historic cohorts of scoliosis patients undergoing repeat x-ray imaging show an 
increased risk of cancer compared to the background population. Especially breast 
cancer has been of concern. Children and young adults are believed to be more 
sensitive to the adverse effects of ionizing radiation.  
When first diagnosed with scoliosis, patients are primarily children or young adults. 
Primary assessments of scoliosis, followed by monitoring of curve progression as well 
as intraoperative imaging result in repeated radiographic imaging. The consequence 
is potential high levels of cumulative dose absorption, and subsequent potential risk 
of increased adverse effects from ionizing radiation. To this day, there is no known 
lower dose limit to which amount of radiation that could potentially be harmful and 
lead to detrimental changes within the body and development of malignant disease. 
Thus, keeping radiation exposure to our patients as low as possible while still 
providing adequate imaging is of great importance.  
Dose optimization is an issue of great concern and much effort has gone into revising 
dose-protocols, optimizing/modernizing x-ray equipment as well as developing new 
techniques. To address the issue of dose optimization, the low-dose EOS scanner was 
taken into use at our institution in the fall of 2014. This particular scanner has been 
shown to markedly reduce radiation dose compared with standard x-ray modalities, 
while at the same time providing images of high quality. 
The aims of the studies in this PhD thesis was to investigate this new EOS scanner 
both with regard to radiation dose exposure and to investigate ways of optimizing low-
dose protocols even further. Another aim was making an overall view of total dose 
accumulation in patients treated for idiopathic scoliosis at our institution including 
conventional x-rays, EOS scans, intraoperative imaging and ancillary CT scans and 
compare these findings with literature. Finally, to investigate and develop a method 
to reduce time spent on precise organ dosimetry with thermoluminescent dosimeters 
(TLDs). 
Five studies were conducted, three of these published in international peer reviewed 
journals. Study I was the first study to report and publish results on organ doses and 
effective dose for the new EOS micro-dose protocol. Claims by manufacturer of level 
of dose exposure was confirmed. Findings on regular standard-dose were comparable 
to previous reports. 
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Studies II and III investigated, and found a way of establishing new reduced dose full-
spine protocols. This was achieved by semi-quantitative phantom image analysis, 
resulting in two clinically validated reduced dose protocols; in study II a protocol for 
3D reconstruction of the spine, and in study III a protocol allowing repeatable 2D 
Cobb angle measurements. 
In study IV a first report was made on total radiation dose from CR, EOS, O-arm and 
ancillary CT during the course of current scoliosis treatment at our institution. A 
survey forwarded to nine international spine centers asking for information on current 
routines regarding scoliosis treatment and radiographic follow-up was used for 
comparison with own institution. The survey showed varying degrees of inter center 
agreement and no strict adherence to current consensus guidelines. 
Study V investigated a way of possibly determining a reduced number of dosimeters 
to be used for organ dosimetry without compromising validity of results. The study 
was based on phantom liver organ dosimetry after exposure in the EOS. By statistical 
and practical analysis, it was found that reliable mean organ dose measurements could 
be performed using less than 25% of available dosimeter allocations. 
The aims of the studies were met. Reliability of measurements were confirmed 
within studies and when compared with literature. Two new dose-optimized 
reduced-dose protocols are ready for clinical application. By evaluating the total 
amount of accumulated radiation dose during treatment of scoliosis a measure to 
evaluate potential risk of radiation induced cancer is at hand. A tool was presented 
proposing a way of  reducing time spent on organ dosimetry without compromising 
certainty of dose  measurements. Currently a strategy of how to implement one or 
both reduced-dose protocols is being worked out at our institution. The tools and 
methods presented in the thesis and those published in international journals are at 
hand for other institutions and for future research. 
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Dansk Resume 
Medicinsk røntgenstråling er den næststørste årsag til at den menneskelige organisme 
udsættes for ioniserende bestråling. Gennem de seneste årtier har brugen af 
medicinske røntgenstråler med deraf følgende ioniserende stråling, specielt fra CT 
skanninger, været stigende. Studier af de som overlevede de amerikanske 
atombombesprængninger i henholdsvis Nagasaki og Hiroshima, har vist at der er en 
direkte årsagssammenhæng mellem den mængde af radioaktiv stråling som den 
menneskelige organisme udsættes for og den deraf følgende risiko for skadelige 
virkninger, som f.eks. stråleinduceret cancer. Flere historiske kohorte studier har 
indikeret at der er en øget forekomst af cancer blandt skoliosepatienter end i 
baggrundsbefolkningen. Dette begrundet i gentagne røntgenundersøgelser af 
skoliosepatienterne. Især den øgede forekomst af mamma cancer hos disse patienter 
har vakt bekymring. Børn og unge mennesker menes at være særligt modtagelige over 
for de skadelige virkninger af ioniserende stråler. 
Diagnosen skoliose bliver oftest stillet i barndommen eller i den tidlige ungdom.  
Forundersøgelser, efterfølgende kontroller af mulig kurve progression, så vel som 
eventuel intraoperativ gennemlysning resulterer i, at denne patientgruppe skal 
igennem gentagne røntgenundersøgelser. Konsekvensen af dette er en potentielt høj 
akkumuleret dosis af ioniserende røntgenstråling, og en deraf øget risiko for  
skadevirkninger. Indtil videre er der ikke nogen kendt nedre grænse for hvilken 
mængde af røntgenstråling der kan lede til skadevirkninger og stråleinduceret cancer. 
Så længe dette er tilfældet er det yderst vigtigt at den mængde stråler som vores 
patienter udsættes for holdes på det lavest mulige niveau, samtidig med at vi sikrer os 
korrekt diagnosticering og behandling. 
Dosisoptimering er et vigtigt fokusområde og mange ressourcer er blevet, og bliver 
fortsat, brugt på at revidere dosis protokoller, modernisere røntgenudstyr og på at 
udvikle nye teknikker.  
For at imødekomme dette behov, tog vi i efteråret 2014 en ny EOS® lav-dosis skanner 
i brug på vores afdeling. EOS skanneren har i tidligere studier vist sig at bruge markant 
færre røntgenstråler end andre røntgenapparater og alligevel samtidig at kunne levere 
røntgenbilleder af høj kvalitet.    
Målene med denne PhD afhandling var at undersøge EOS skanneren i forhold til  
hvilken mængde af røntgenstråler den eksponerer vores patienter for, og  at belyse 
mulighederne for at optimere lav dosis protokollerne yderligere. Et yderligere mål var 
at undersøge og belyse brugen af røntgenstråler i forbindelse med undersøgelse og 
behandling af skoliosepatienter på vores afdeling. Herunder almindelig røntgen, EOS, 
intraoperativ røntgengennemlysning og CT, samt evt. supplerende billeddiagnostiske 
undersøgelser, og sammenligne dette med litteraturen. Endelig, at undersøge 
muligheden for at udvikle en metode til at nedsætte den tid der bruges på at foretage 
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præcis organ dosis monitorering med thermoluminescente røntgen dosimetre (TLD 
tabletter).   
Afhandlingen bygger på fem videnskabelige studier, tre af disse er blevet publiceret  i 
anerkendte peer reviewede internationale tidsskrifter,  de to sidste er indsendt til 
bedømmelse og afventer review. I studie I undersøgte og belyste vi som de første 
absorberet organdosis og helkropsdosis ved brug af den nye EOS ”micro-dose” lav 
dosis protokol. Vi bekræftede fabrikantens postulat om at en helkropsskanning i to 
plan resulterede i en røntgeneksponering svarende til mindre end en uges naturlig 
baggrundsstråling. Øvrige fund med almindelig ”standard-dose” protokol var 
sammenlignelige med tidligere publicerede studier. 
Studierne II og III, undersøgte og fandt en måde at etablere nye dosis optimerede EOS 
protokoller til undersøgelse af columna totalis (”full-spine”). Dette blev opnået ved 
semikvantitativ billedanalyse baseret på røntgenundersøgelser af et antropomorft 
(menneskelignende) røntgen fantom. Resultatet blev to protokoller; i studie II, en 
protokol til brug ved 3D rekonstruktion af columna, og i studie III, en protokol til brug 
ved 2D Cobb vinkelmålinger. 
Studie IV belyste den totale røntgenstråling fra almindelig røntgen (CR), EOS, O-arm 
CT under operationer, samt eventuelle yderligere CT skanninger foretaget i 
forbindelse med behandling for skoliose på vores rygcenter.  Et web-baseret 
spørgeskema blev sendt til ni forskellige internationale rygcentre med henblik på 
belysning af behandlingsmønstre og  procedurer for røntgenopfølgninger i forbindelse 
med behandling af  patienter med idiopatisk skoliose (IS). Resultaterne blev 
sammenlignet med algoritmerne på vores center. Spørgeskemaet viste nogen grad af 
uoverensstemmelse klinikkerne imellem og ingen fuldstændig overholdelse af 
internationalt aftalte retningslinjer/ konsensus. 
Studie V undersøgte muligheden for at reducere antallet af TLD tabletter som det er 
nødvendigt at bruge i forbindelse med organdosimetri uden at kompromittere 
validiteten af resultaterne. Studiet blev baseret på røntgenfantom dosimetri, med 
leveren som målorgan. Det blev konkluderet, at korrekt organdosimetri kan foretages 
ved brug af mindre end 25% af tilgængelige målepositioner. 
Målene med afhandlingen er nået. Pålideligheden af vores målemetoder blev 
bekræftet studierne imellem, og når man sammenligner med tidligere publicerede 
studier. To nye lavdosis ”full-spine” protokoller er klar til klinisk implementering. 
Ved evaluering af den totale mængde ioniserende stråling som vores patienter 
udsættes for i forbindelse med skoliose udredning samt behandling har vi fået et 
redskab til vurdering af den samlede risiko for stråleinduceret cancer for vores 
skoliose patienter. En metode til optimering af arbejdsgangen i forbindelse med 
organ- og helkropsdosimetri med TLD tabletter er blevet præsenteret. 
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På nuværende tidspunkt arbejder vi på en strategi for implementering af den ene 
eller begge af de to dosis optimerede protokoller i vores rygcenter. Redskaberne og 
metoderne præsenteret i denne afhandling og publiceret i internationale tidsskrifter 
er tilgængelige for andre centre og fremtidige forskningsprojekter. 
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Introduction 
Ionizing radiation and medical imaging 
The type of radiation emitted by medical x-ray modalities is ionizing radiation. 
Ionizing is radiation that carries enough energy to induce the release of electrons from 
a molecule or an atom(1). When tissue is under the influence of ionizing radiation, 
energy is released and might cause changes in surrounding tissues, causing tissue 
damage, and possible detrimental effects. Radiation detriment is a way to quantify 
cancer incidence, mortality of cancer and hereditary effects as a result of ionizing 
radiation to the body(2). The general use of medical imaging involving ionizing 
radiation has been on the rise in the past decades(3), the development of better and 
more precise imaging modalities as well as the need and wish for more high-definition 
x-ray solutions have resulted in medical imaging being the second highest cause of 
ionizing radiation in the western world. CT scans make up the major part of the 
exposure coming from medical imaging. Figure 1 shows the proportional relationship 
between the frequency of examinations in Europe and the accumulated dose from 
medical imaging. 
 
The number of fluoroscopy guided interventions, among these minimal invasive 
surgery of the spine have also been increasing. These methods are often faster, less 
invasive and less traumatic to the patients resulting in faster recovery. However, most 
of these methods require extensive use of x-ray imaging (fluoroscopy or CT). 
Furthermore, in spinal surgery there has bend a trend towards the increased use of  
intraoperative CT-based navigation for safe instrumentation of the spine(4). 
A Swiss study (5) found that the average annual exposure from medical imaging per 
capita was 1.2 mSv. The worldwide average natural background radiation has been 
Figure 1, Euramed 2019, presented at  ERPW 2019, Stockholm. 
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estimated at 2.4 mSv (range 1-10)(6), in Denmark the background radiation from 
natural causes is estimated at 3 mSv per year and approx. 1 mSv from medical 
diagnostics ((7).  
Health effects from radiation 
Adverse health effects from radiation can be divided into two categories; deterministic 
effects and stochastic effects. 
Deterministic health effects 
The deterministic effects occur when an immediate dose exposure exceeds the 
threshold for acute tissue damage, eg. skin reddening, burns, organ failure, sterility, 
cataract, hypothyroidism, etc. Table 1 illustrates examples of threshold levels for 
deterministic tissue damages from radiation. Doses below thresholds cause no 
deterministic effects. 
Table 1, Deterministic Health Effects  
Examples of thresholds of occurrences for various Effects 
Organ or tissue Dose in less 
than two days, 
Gy. 
Type of effect Time of 
occurrence 
Whole body 
(bone marrow) 
1 Death 1-2 months 
Skin 3 Rubor 1-4 weeks 
6 Burn 2-3 weeks 
4 Temporary hair loss 2 to 3 weeks 
Thyroid 5 Hypothyroidism 1st-several years 
Eyes 2 Cataract 6months – 
several years 
Gonads 3 Permanent sterility Weeks 
Sources: ICRP report 118(8) and the International Atomic Energy Agency 
(IAEA). 
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Stochastic health effects 
Stochastic health effects from radiation are changes and damage to cells, occurring by 
chance and often with a latency of many decades.  The  stochastic risk from radiation 
is believed to have no lower threshold of dose, and the risk of adverse health effects 
to be proportional with amount of dose absorbed to the human body(2). The most 
important health effect from ionizing radiation is cancer. The Linear-Non-Threshold 
model (LNT) is the most commonly used way to depict the assumed proportional 
relationship between absorbed radiation dose and the risk of cancer. Figure 2 shows 
the LNT model as well as other theoretic models for health risks from exposure to 
low-dose radiation. 
 
Potential risk from low-dose radiation 
In medicine risk is the probability of an adverse outcome. Modern risk estimates for 
an irradiated population are derived from the atom bomb survivor studies. The atom 
bomb survivor studies have reported an increased risk of cancer among people 
exposed to ionizing radiation(9,10), and found a direct correlation between the amount 
of radiation an individual is exposed to and the risk of developing cancer. The LNT 
currently is the most widely used model used to estimate the risk from low-dose 
ionizing radiation, and is recommended by the United Nations Scientific Committee 
on the Effects of Atomic Radiation (UNSCEAR), the International Commission on 
Radiation Protection (ICRP) and the National Council on Radiation Protection and 
Figure 2, Linear-Non-Threshold model (blue line) and other theoretic models for 
risk assessment in  relation to radiation dose. Canadian Nuclear Safety 
Commission fact-sheet(2013)(80)   
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Measurement (NCRP) (2,6,11). As described above this model assumes direct 
proportional relationship between the amount of radiation dose absorbed and the 
derived risk of radiation induced cancer.  
How to quantify risk 
One way to describe the risk of adverse health effects posed by ionizing radiation is 
the term effective dose. According to the ICRP publication 103(2), effective dose is a 
theoretic measure, representing the full-body stochastic risk, the risk of developing 
cancer as the result of full-body or partial radiation exposure to the body. Effective 
dose is expressed in miliSieverts (mSv) and is calculated based on the summed tissue 
equivalent dose for all organs of the body. The absorbed radiation dose in tissue is 
expressed in Gray (Gy), 1Gy = 1 joule/kilogram (J kg-1). The unit for effective dose 
is the same as for absorbed dose, J kg-1, and it is expressed in (mSv)(2). For medical 
x-rays 1 Gy = 1 Sievert.   
When a population group of one million people are exposed to one Sievert, it is 
theorized that 50 people will die prematurely as a cause of radiation-induced cancer 
ICRP(2). This means that a typical computed tomography scan of 10 mSv will result 
in a radiation-induced premature death in one out of 2000 scans. One premature death 
in 2000 scans might not seem a lot, but in 2015 alone, 919.500 CT scans were 
performed in Denmark (12). This would theoretically result in 460 premature deaths 
for one year of CT scans in Denmark. The lifetime attributable cancer risk based on 
15mSv has been previously been reported to be 0.08-0.17% (13).  
Scoliosis 
Idiopathic scoliosis (IS) is a three-dimensional (3D) deformity of the spine, defined 
by a 2D Cobb angle of more than 10 degrees. It usually develops in childhood and 
early adolescence, the prevalence of IS in childhood has been reported to be anywhere 
from 2% to 5.2%(14,15) with a female to male ratio of approx. 5:1(15). The first 
assessments, continuous monitoring of potential curve progression as well as 
intraoperative imaging in case of surgery result in repeated radiographic imaging of 
these patients, and subsequent high cumulative levels of absorbed radiation. In a 
cohort study by Ronckers et al(16) more than 4,000 patients diagnosed with scoliosis 
in childhood were exposed to numerous x-rays during the course of assessment and 
treatment and followed for more than 40 years. The standard mortality rate of dying 
from breast cancer for this group of patients was 1.68 (95% CI: 1.38–2.02) compared 
with the background population(16). In a more recent study looking at adverse health 
effects 26 years after exposure to follow-up x-rays for scoliosis, an increased risk of 
endometrial cancer was found(17).  
Especially the risk for children and young adults is of concern, as these patients are 
thought to be more susceptible to ionizing radiation. This group of patients have a 
longer life expectancy and thus more time to develop adverse effects to radiation 
exposure(8). The latency after exposure to radiation before cancer develops often is 
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one or more decades(6,18,19). The gold standard for radiographic imaging is the 
upright coronal plane, posterior-anterior (PA) and the sagittal plane, lateral full-spine 
x-ray film(20,21). Previously coronal plane imaging was performed in the 
anteroposterior (AP) plane. However, x-ray dosimetry showed radiosensitive organs 
received a 20-50 percent higher dose in AP than in PA plane(22,23). The most 
radiosensitive organs such as the breasts, thyroid glands and gonads are all exposed 
during scoliosis radiographic examination. By PA positioning, the radiation to these 
organs are to some extent reduced. One study showed 8 times more radiation to the 
breasts and 4 times more to the thyroid glands when comparing AP with PA 
projections(24). CT scans comprise the majority(5) of all diagnostic imaging 
involving ionizing radiation. The radiation dose emitted from single x-rays is much 
lower, but still not negligible. Dose reports for full-spine radiography range from 
0.5mSv-3.5mSv(25–27). Scoliosis patients, in particular, are subjected to numerous 
x-rays, thus, often receiving high levels of accumulated doses of ionizing radiation 
even when not counting CT. A typical course of monitoring and treatment for scoliosis 
includes coronal and lateral full-spine images every 3-6 months from the time of 
diagnosis until spinal maturity or until a curve in need of surgical treatment is reached. 
Previous studies(17,24,28,29) report that a typical scoliotic patient receives approx. 
15-20 full-spine x-rays. With a range from less than 5 to more than 50 x-rays, and an 
average accumulated dose of 5.4-15mSv(13,24,30). Even though non-ionizing 
imaging methods such as MRI and ultrasound have evolved and make up a substantial 
amount of all diagnostic procedures, ionizing radiation still makes up the vast majority 
of diagnostic imaging procedures(31). For the monitoring of scoliosis and other spinal 
deformities there are few alternatives to radiographic imaging involving ionizing 
radiation. 
Keeping exposure of ionizing radiation from medical imaging low 
As of now there is no known lower threshold to the amount of radiation which might 
cause adverse health effects such as cancer. It is of great importance for clinicians to 
be aware of the potential detrimental effects from ionizing radiation and only use 
medical imaging when there is a just cause, as per the ALARA (As Low as Reasonable 
Achievable) principle(32). The benefit of exposure needs to exceed the risk of 
detriment(2). 
Dose optimization 
Much effort has been put into lowering the radiation dose to our patients as per the 
ALARA principle, still providing high quality imaging for optimal treatment and 
assessment. Ways of keeping dose at a minimum are numerous and often very logical. 
Optimization of radiation dose from medically induced exposures can be subdivided 
into a number of principles, such as: reducing the numbers of radiographic exposures, 
reducing the time of exposure, minimizing the field of exposure, using diagnostic 
reference levels (DRL) to optimize radiographic protocols, continuous education of 
users,  modernizing x-ray equipment and developing new modalities. None of these 
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principles are able to stand completely alone, and most often a number of principles 
are combined, evaluated and improved. 
Dosimetry 
Dosimetry is the cornerstone of radiation dose evaluation and dose optimization. 
Modern dosimetry encompass a variety of methods spanning in vivo and in vitro 
measurements. Dosimetry can be made externally both as in vivo or in vitro 
measurements as well as ambient measurements and animal measures. Internal in vivo 
dosimetry is often very technically demanding and the most commonly used methods 
are either phantom based dosimetry, the mathematical method using the Monte Carlo 
PCXMC method(33) or a combination of different methods. State of the art 
information on absorbed radiation dose is achieved by anthropomorphic phantom 
dosimetry. This method uses internal x-ray dosimeters in a human like x-ray phantom 
imitating the human body. By summing measured tissue equivalent doses from 
different organs within the phantom a full-body absorbed dose can be estimated in 
terms of effective dose. A different way of estimating effective dose is by the use of 
the PCXMC mathematical phantom in combination with measured skin entrance 
doses. Both methods are approved by the ICRP(2), but it is our belief that phantom 
dosimetry imitates better in vivo measurements than PCXMC, thus one of the main 
aims of this thesis was to evaluate different x-ray modalities and settings in two 
humanlike anthropomorphic phantoms. 
The EOS Low-dose slot-scanning system 
The promises from the industry of new imaging systems with lower radiation dose 
and higher image quality are plenty. One such system is the EOS (EOS®-imaging, 
Paris, France) biplanar slot-scanning system. The EOS system is based on a new 
revolutionary gaseous particle detector with a multi-wire proportional chamber, 
invented by Professor George Charpak in 1992, and for which he received the Noble 
Prize in Physics(34). The multi-wire proportional chamber is ultrasensitive and as a 
result less x-rays are needed for detection, and the patients are subsequently exposed 
to less radiation. The EOS uses stereo-radiography which allows for simultaneous 
coronal plane and sagittal plane full-body images in weight bearing position. The EOS 
can be used for spine as well as pelvic and lower limb radiographic evaluations. At 
our spine department we use the EOS for full-spine imaging and full-body postural 
assessment. The system provides information on spine deformities in a classical 2D 
perception, but also offers a 3D reconstruction option which allows for viewing 
deformities in a 3D perspective as well. The 3D reconstruction option is semi-
automated and has been clinically validated(35). Image quality had prior to this study 
been reported to be comparable to existing x-ray systems, some in favor of EOS 
(26,36), some in favor of conventional radiology (CR)(37). 
Reduced dose with the EOS and gaps of knowledge 
Reports on dose exposure with the EOS system prior to this study were  already 
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numerous(26,36–41), reporting anywhere from 2 to more than 40 times reduced dose 
compared with conventional x-ray systems. The system comes with a standard low-
dose setting and a newer micro-dose option the latter has been claimed by the 
manufacturer to emit less radiation than one week of natural background radiation of 
63µSv (EOS-imaging, figure 3).  
However, most reports were based on 
skin surface entrance dose differences, 
mathematical PCXMC phantoms and 
claims by manufacturer (26,34,36–
38,41,42). Few studies had looked at 
organ doses and effective doses based 
on anthropomorphic phantom 
dosimetry(40,43). Damet et al 
(2014)(40) looked at organ dose and 
effective dose for EOS standard-dose 
protocol and compared with CR. They 
only used a fraction (54-58) out of 
more than 296 available dosimeter 
locations, theoretically compromising 
the validity of their results as mean 
organ dose values could vary 
significantly depending chosen 
dosimeter placements. No reports based on anthropomorphic phantom dosimetry had 
been made on the new EOS micro-dose protocol. The aim of Study I was to investigate 
the EOS micro-dose protocol with regards to organ dose and effective dose in order 
to verify claims by manufacturer as well as compare with organ dose and effective 
dose reports based on the PCXMC method. Furthermore, Standard-dose 
measurements and CR measurements were performed to compare with previous 
reports.   
A further question was whether the micro-dose protocol could be even further reduced 
which was investigated in studies II and III. Could it be possible to reduce dose even 
further than this very low dose micro-dose protocol and still obtain images with 
sufficient quality to treat and diagnose patients correctly. If indeed possible, doses 
would be so low that barely any radiation risk would be associated with this imaging.   
Total accumulated dose from all x-ray modalities  
In order to estimate the magnitude of radiation dose exposure and the subsequent 
potential risk of detrimental effects, an overview of  total accumulated dose from all 
x-ray modalities is needed. Cumulative doses based on routine CR and fluoroscopy 
on scoliotic patients undergoing routine assessment and treatment for scoliosis has 
been reported in a number of studies(13,16–19). Reports on the mean frequency and 
total number of full-spine radiographs range approx. from 10 to more than 
Figure 3, EOS-imaging product 
folder, claiming that one full-spine 
biplanar scan is less than one week of 
natural background exposure.   
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20(16,17,19). However, no reports on total cumulative dose from CR, EOS 
intraoperative fluoroscopy/ or CT existed prior to this thesis. Study IV aimed at 
making an overall assessment of total cumulative dose from all modalities in a historic 
cohort of patients treated for scoliosis at our institution.  
Time spend on dosimetry and validity of measurement certainty 
The experiences of studies I and III illustrated the great time expenditure and 
questions towards validity and certainty of previously reported results(40,42) were 
raised. Based on these considerations a  methodological study, Study V, was 
conducted in order to look at the possibility of estimating mean organ dose from a 
reduced number of dosimeters, thus reducing time on organ dosimetry. Another aim 
was to validate measurement certainties of studies I and III. There is as of now no 
gold standards within this field and the method was experimental.
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Aims and Hypotheses 
 
Aims Studies I-V 
The aims of this PhD thesis was, as described in the summary of this thesis, to 
investigate the EOS biplanar low-dose scanner (EOS® -imaging, Paris, France), 
investigating radiation dose exposure and full-body radiation dose absorption from 
current standard dose protocol as well as the new micro-dose protocol (Study I). 
Studies II and III aimed at establishing and clinically validating new optimized EOS 
low-dose protocols. The aim of Study IV was to illustrate the total accumulated 
radiation dose, from all modalities, that  a typical scoliosis patient receives during a 
full treatment or monitoring cycle at our institution. The fifth and final study aimed to 
evaluate different factors influencing organ dosimetry and to develop a method that 
could potentially reduce the time spent on precise phantom organ dosimetry, using 
TLDs.   
 
Hypotheses 
Study I 
It was hypothesized that organ dose measurements and effective dose estimations 
from micro-dose exposure to anthropomorphic phantoms could be obtained by an 
improved version of a previously published method. 
 
Study II 
It was hypothesized that the radiation dose delivered to patients by the already low 
dose micro-dose protocol could be reduced even further without compromising 
reliability of 3D reconstructions of the spine. 
 
Study III 
It was hypothesized that the radiation dose delivered to patients by the already low 
dose micro-dose protocol could be reduced even further without compromising 
reliability of coronal plane 2D Cobb angle measurements.  
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Study IV 
It was hypothesized that the magnitude of absorbed radiation dose varies greatly 
depending on radiographic follow-up protocols, and that variation of radiographic 
follow-up algorithms for idiopathic scoliosis exists among different spine centers.  
 
Study V 
It was hypothesized that a method for determining optimal placement of 
thermoluminescent dosimeters (TLDs) as well as optimal numbers of TLDs could be 
obtained, allowing for precise repeated and time efficient monitoring of organ doses 
within an anthropomorphic phantom. 
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Materials and Methods 
Design  
The five studies of this thesis spanned over a variety of designs all centered around 
ways to report and investigate radiation dose from full-spine imaging as well as 
exploring ways of influencing the amount of radiation dose used. The first study was 
a comparative and descriptive study with a focus on first dose report on a new EOS 
scan protocol  as well as comparing new and repeated results with existing literature. 
The second and third studies were prospective clinical validation studies with 
technical notes, using image quality analysis to develop new scan protocols and 
subsequently validate these protocols in a clinical prospective manner. The fourth 
study was a retrospective cohort study describing total accumulated radiation dose to 
patients undergoing treatment for scoliosis at our institution and in conjunction with 
this an internet based survey for expert opinions/trends on scoliosis treatment and 
radiographic follow-up for comparison with own institution. The fifth, a 
methodological study, using advanced statistic modelling and phantom dosimetry to 
evaluate the position and minimum number of TLDs needed for accurate liver organ 
dose measurements within an anthropomorphic phantom, aiming at reducing time 
spent on organ and full-body dosimetry. 
  
Ethical considerations 
All studies involving patients and identifiable human data were conducted according 
to the Declaration of Helsinki 1975 (8th revision2013)(44) on ethical principles for 
medical research involving human subjects.  
Studies I and V did not involve patients or patient data and no ethical approval was 
needed.  
Studies II and III were conducted at a pediatric center in Paris, France. Ethical 
approval was obtained from the Local Ethical Health Committee.  
Study IV involved access to patient files, all data was handled according to Danish 
law, and an approval to conduct the study as well as storing of data was obtained by 
the North Denmark Region, project registration number (2019-76). Registration at the 
national data protection agency is no longer required. The North Denmark Region 
Committee on Health Research Ethics was informed of the study and confirmed that 
the project did not have to be submitted to the above committee.  
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Study populations 
Study I 
The “population” consisted of two humanlike CIRS-ATOM anthropomorphic 
dosimetry phantoms(45) (Computerized Reference System, Inc. Norfolk, VA, USA). 
A  pediatric phantom resembling a five year-old child, type 705-D, and an adult female 
phantom representing an adolescent female, type 702-D. 
Anthropomorphic means humanlike and both phantoms are architectured to resemble 
the human body with dosimetry options within 21 anatomically placed inner organs 
as well as the full skeleton.  Each phantom consists of tissue equivalent epoxy resins 
with aged matched density for: average soft tissue, average bone, average lung, 
average brain and average breast tissues. The phantoms are divided into a number of 
25mm thick axial sections, within each section are organ specific dosimetry 
locations/holes each with a vertical cylinder shaped tissue equivalent plug. 
Thermoluminescent (TLD) dosimeters (described later in the text) can be fitted within 
these cylinders for organ dosimetry. Owing to the tissue specific structures of the 
phantoms, the phantoms also have a high grade of image quality control properties. 
Figure 4 shows the pediatric and the female adult phantoms in the EOS scanner and 
the resulting biplane images.  
 
 
  
Figure 4, The pediatric phantom and the female adult phantom in the EOS 
scanner and subsequent two-plane imaging result(female adult). 
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Figure 5 shows a section of the same phantom and the numbered 5 mm locations for 
the placement of tissue equivalent cylinders and dosimeters as well as larger holes and 
plugs intended for image quality control of the lung and soft tissue of the abdomen. 
 
Studies II and III 
Phantom: The pediatric phantom 
described in study I was used for 
semi-quantitative image analysis 
and dosimetry.  
Pilot group: Four children, in the 
ages of 5-10 years of age, 
attending regular scheduled 
follow-up full-spine radiographic 
controls were offered micro-dose 
imaging and different reduced 
micro-dose imaging instead of 
regular EOS standard-dose 
imaging. Patients were informed about the study in both written and oral manner, and 
accepted to take part in the study. Parents of the children signed a written form of 
consent. 
Validation group, Study II: A consecutive cohort of 18 children, 12 years of age or 
younger, all were scheduled for routine radiographic follow-up of their scoliosis at the 
outpatient clinic with EOS biplanar imaging. Written and oral information regarding 
the project was provided and a written form of consent was signed by parents.  
Validation group, Study III: A consecutive cohort (a cohort different from study II) 
of 23 children, 12 years of age or younger, was included in the same manner as the 
study population of study II. 
  
Figure 5, the adult female phantom in the 
scanner and disassembled, illustrating 
examples of different phantom slices and 
placement of inner organs. 
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Study IV 
All patients 18 years of age or younger within the 
North Denmark Region1 in the years 2013-2016 
who were undergoing assessment, treatment or 
routine follow-up for idiopathic scoliosis (IS). 
Patients were identified from International 
Classification of Diseases (ICD) coding within the 
North Denmark region hospital registries. All 
patients with neuromuscular disorders, mentally 
retarded or suffering from other severe conditions 
were excluded. Final inclusions were 61 patients. 
Hospital records, medical charts and the PACS 
(Picture archiving system) were scrutinized for 
data on radiographic imaging, length and type of 
treatment. 
Study V 
The female phantom described in study I. 
 
Outcome parameters 
The overall outcome parameter throughout the papers constituting this thesis is the 
quantification of radiation dose in terms of effective dose. Effective dose is a 
theoretical parameter developed by the International Commission on Radiation 
Protection (ICRP)(2) combining measured radiation doses in organs with specific 
tissue-weights based on empirical and theoretic data to define the full-body stochastic 
health risk, the risk of cancer induction by exposure to ionizing radiation. 
Effective dose can be used to compare dose outputs from different x-ray modalities 
and is an important measure for dose optimization. By retrospectively collecting data 
                                                          
1 (North Denmark Region, population size 2016; 585,000) 
Figure 6, A 10 year-old child undergoing pilot 
images for study 3. To the left “Nano-dose” to 
the right micro-dose illustrating a 6-fold dose 
difference during full-spine radiography.   
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from previous medical imaging using ionizing radiation effective dose can be 
estimated, and an evaluation of prior and current magnitude of dose exposure and 
absorbed cumulative radiation dose can be evaluated and quantified. Figure 7 
illustrates how effective dose is calculated. 
 
 
 
 
 
 
 
Primary outcome measures 
Study I, primary outcome measures were quantification of radiation dose based on 
phantom dosimetry and subsequent evaluation of organ doses and derived effective 
doses. 
Studies II and III, one outcome measure was quantification and optimization of 
radiation during development of reduced-dose radiation protocols with regards to 
effective dose.   
Study II, a second outcome measure was intra- and inter observer reliability in terms 
of variation from the mean in order to quantify uncertainty of 3D reconstruction of 
the spine in relation to current international standards. 
Study III, a second outcome measure was intra- and inter observer reliability in terms 
of variation from the mean in order to quantify uncertainty of Cobb Angle 
measurements in relation to current international standards.  
Study IV. One outcome measure was the quantification of absorbed dose magnitude 
in terms of effective dose based on retrospectively collected data on x-ray history in 
a retrospective cohort of scoliosis patients. A second outcome measure was the 
objective proportional relationship between spine centers in trends of radiographic 
assessment of scoliotic patients.  
 
 
 
Figure 7 
Calculating Effective Dose 
Effective dose (E), 𝑬 =  ∑ 𝒘𝑻𝑯𝑻 
The sum all organ equivalent doses (𝐻𝑇), 
multiplied by specific organ tissue 
weights(𝑤𝑇) 
Equivalent organ dose is equal to mean organ 
dose for medical imaging. 
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Study V. One outcome measure in study V was in terms of possibility of reaching 
correct mean organ dose from dose measurements and statistical modelling, with a 
reduced number of TLDs. This was shown by regression coefficients and graphical 
illustrations as well as logical testing. There is as of now no gold standards within this 
field and the method is experimental. 
A second outcome measure was the illustration of decreased sensibility of TLD 
dosimeters used for organ dose dosimetry in terms of decreasing magnitude of counts 
absorbed in the dosimeters over time.  
Organ Dosimetry 
Phantoms 
Anthropomorphic phantom organ dosimetry is the measurement of absorbed radiation 
dose within human-like phantoms. The phantoms described above, were used for 
organ dosimetry and calculations of mean organ doses as well as effective doses.  
The female adolescent phantom holds 294 internal dosimeter positions including 40 
located within the breasts. All dosimeter positions were used in study I. For study V 
only the 28 liver specific positions were used.  
The pediatric phantom holds 180 internal dosimeter positions. All dosimeter positions 
were used for the full-body absorbed dose evaluations of studies I and III. 
On the surface of both phantoms, symmetrically placed TLDs allowed for 
measurement of skin entrance and skin exit doses. The physical dimensions of the 
phantoms are summarized in Table 2.  
Table 2, Physical dimensions of anthropomorphic phantoms used in the thesis 
Description Height  Weight Thorax dimensions  
Adolescent female 160 cm 55 kg 20 cm x 25 cm 
Pediatric 5 year-old 110 cm 19 kg 14 cm x 17 cm 
 
Dosimeters  
For the use of dose measurements, thermoluminescent (TLD) dosimeters of the MCP-
N type was used (MCP-N, Krakow, Poland).  The MCP-N TLD is a solid lithium-
fluoride dosimeter covered with magnesium, copper and phosphorus, also commonly 
referred to as a LiF-Mg,Cu,P dosimeter. The MCP-N is highly sensitive dosimeter 
and is well suited to use for low-dose imaging owing to a very low detection 
threshold(46,47). The basic function of the dosimeters is to absorb radiation dose by 
trapping electrons. The absorbed electrons are released when the TLD is heated in a  
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TLD-reader and translated into radiation dose in terms of mSv. The Rados RE-2000 
reader (RadPro International GmbH, Wermelskirchen, Germany) was used in the 
studies involving dosimetry. Before each exposure of TLDs they need to be reset and 
calibrated. Resetting TLDs to “zero-value” (the emptying of TLDs) is done by 
annealing (heating in an oven to release all captured electrons). The reset TLDs are 
then read in the TLD reader for zero-values. The mean zero value is calculated and 
recorded. All TLDs are subsequently exposed to a known radioactive source, in this 
case a strontium-90 source placed within an irradiator. The irradiator, IR-2000 
(RadPro International GmbH, Wermelskirchen, Germany) was used. After irradiation 
by the known radiation source the TLDs need to be read (measured) again in the TLD 
reader. Calibration reference is measured and a mean calibration value is calculated 
from all TLDs read. Now, the TLDs are ready for installment in the phantom. Once 
exposed to an x-ray source the EOS, CR or another modality, the procedure is done 
reversely. All TLDs are removed from the phantom, installed in cassettes and cassette-
magazines. Mean zero values of the TLDs, mean reference dose calibration values are 
typed into the TLD reader software and the TLDs can now be read by the TLD reader 
and absorbed doses read out. The process of preparing TLDs for exposure, installing 
into phantom, scanning phantom, removing TLDs in correct order by installing them 
into numbered cassettes and reading out doses takes in excess of 24 hours of 
continuous work, for one phantom exposed in one position. This is not counting the 
time of transport between hospital and x-ray lab, and not counting the time of 
subsequent calculations of mean organ doses and calculations into effective dose. The 
work  needs to be done in partial darkness as the TLDs are light sensitive collect false 
“radiation” if exposed to light. Figure 8 shows the dosimetry lab setup.  
 
 
 
Figure 8, (a) TLDs, (b) cassettes and magazine, (c) from left; annealing oven 
(TLDO. PTW, Freiburg Germany), irradiator (IR-2000) and reader (Re-2000) 
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Imaging systems 
EOS 
The EOS®  (EOS-imaging, Paris, France) biplanar slotscanning system was used for 
dose exposures in studies I-III and V and used as reference for dose calculations in 
study IV. The EOS scanner is a low-dose slot-scanning system that has been 
developed in order to acquire high quality imaging at very low doses(34,38).  
  
The EOS scanner uses two orthogonal x-ray beams scanning the patient vertically in 
a time span of 8-20 seconds, while yielding simultaneously a coronal and lateral 
image. The images are made in weight bearing position and the patient is placed in 
the scanner as shown in figure 9 in either anteroposterior-lateral (APL) or posterior-
anterior-lateral (PAL) positioning. Figure 10, illustrates the direction of the field of 
scan in relation to the EOS and the patient. 
Figure 9. Left, patient in EOS scanner (Reproduction of figure(left) with 
permission of EOS-imaging). Right, the resulting two-plane image after a full-
body scan with standard-dose settings. 
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The EOS scanner can be used for full-spine radiography to assess postural balance. 
Some other uses are evaluation of pelvic parameters and evaluation limb length 
discrepancies. The EOS scanner comes with a 3D option for semi-automated 
reconstruction of the spine. 
Conventional digital radiology (CR) 
A conventional digital radiology system (Siemens Ysio Max, Malvern, PA, USA) was 
used for in-house exposure of phantoms for comparisons of absorbed doses in study 
I.  
Exposure of phantoms for dose measurements 
Study I 
full-spine imaging was performed in PAL and APL for both phantoms in both the 
EOS scanner and with the CR system.  
EOS  
The phantoms were scanned 20 times before measurements of dose and normalization 
into one scan by dividing by the number of scans a method described by Damet et al 
(2014)(40) in order to achieve sufficient dose for measurements.  
 
 
Figure 10, Direction of scan fields of the EOS biplanar scanner 
(reproduction of figure with the permission of EOS-imaging) 
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CR  
The phantoms were subjected to standard default scoliosis protocols for a child and 
an adolescent. Imaging was performed as a pair of scan-cycles, first five scans in AP 
or PA and then five  scans from lateral right side of the phantom, the less 
radiosensitive side(22,23). Figure 11 shows the pediatric phantom in the Siemens 
conventional x-ray modality (Siemens Ysio Max). 
 
 
 
 
 
 
 
Study III 
Five consecutive EOS nano-dose scans were performed in APL and normalized into 
one scan in order to compare with theoretical dose reduction. 
Study V 
The female phantom was exposed in three different positions: APL and at an axial 
rotation of 10 degrees either clockwise or counterclockwise in relation to APL 
positioning. Five consecutive EOS standard-dose scans were performed, at seven 
different occasions, for each of the three positions. Each occasion of five scans was 
normalized into one scan similarly to study III. 
 
Figure 11. The 5 year-old pediatric phantom undergoing CR with the Siemens 
Ysio Max System. Left in lateral positioning. Right in AP positioning. 
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Calculation of organ dose 
Calculation of mean organ doses was done  by adding all individual TLD measures 
from within one organ after subtraction of mean ambient background dose and 
dividing by the number of scans: : ?̂?𝑜𝑟𝑔𝑎𝑛 =
1
𝑛.𝑜.
∑
𝑑𝑖−?̅?𝑎
𝑛
𝑛.𝑜.
𝑖=1  
Where mean ambient ?̅?𝑎was calculated as the mean of four non-exposed TLDs that 
were calibrated and read out along with the number (n.o.) of TLDs used for organ 
dose measurements. 
Establishing reduced dose protocols in studies II and III 
In order to establish new reduced dose protocols in studies II and III, semi quantitative 
image analysis was based on a number of phantom images conducted at a consecutive 
number of images with  decreased dose settings. The EOS settings of current (mA) 
and speed of scan was changed either by  decreasing the current or increasing scan 
speed, or both of the latter two. The current and speed settings are both directly 
proportional to the magnitude of radiation dose. When decreasing current by 50% the 
resulting radiation dose is 50% lower and by increasing speed by 50% radiation dose 
decreases by 50%.  
Considerations taken when the reduced-dose protocols were defined: Objective 
measures were used to determine the minimum dose that yielded acceptable image 
quality. The definition was inherently subjective, since only one observer was 
implicated, but efforts were taken to make it as objectively as possible.  
Semi-quantitative images analysis: The actual semi-quantitative image analysis 
consisted of a scale from 1-5, the main investigator performed a series of blinded 
grading of sections of each phantom in different exposure settings (APL, PAL or axial 
rotation imitating scoliosis), shown in random order. 1= very good, 2=good, 3 
acceptable, 4= poor, 5=very poor. The images were graded against visibility of 
different anatomical landmarks and the possibility of making out vertebral endplates, 
depending on whether it being for the 3D reconstruction or the 2D Cobb angle use. 
The grading was not one of the main results of the study, just a necessary intermediate 
step. The four best settings according to the semi-quantitative analysis were used in 
vivo for pilot imaging on a group of four children. Figure 12 shows examples of 
images used for grading. The preliminary in vivo pilot measurements confirmed the 
readability of the x-rays before clinical application to the prospective cohort.  
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Figure 12. Examples of images used for grading  
(images have been resized to fit this page) 
 
 
 
 
 
 
 
3D Reconstruction  
3D reconstruction with the EOS system is a validated semi-automated feature(35) that 
comes with the EOS system and allows for reconstruction of the spine as well as 
generation of a report where important spine parameters are presented. The 
reconstruction is performed by trained/ certified operators, recognizing and adjusting 
a semi-automated “frame” for each vertebra of the spine. Figure 13 shows 3D 
reconstruction of a spine and the result. Two 3D reconstructions were done for each 
patient by each of the three operators over a three week time span. 
 
 
 
Figure 13. Reconstruction of the spine, using semi-automated technique. 
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2D Cobb angle measurements 
Nano-dose protocol the protocol with the lowest dose of the latter was chosen for 2D 
Cobb angle measurements. The Cobb angle(48) is a widely accepted measure for 2D 
curve magnitude in scoliosis. The angle is measured between the upper endplate and 
the lower endplate of two vertebrae at the extremes of a scoliotic curve. 
Measurements, one at a time were done in random order, three times for each patient 
by each of five operators over a two week period of time.  
Study IV, Conducting an evaluation of cumulative radiation dose 
A retrospective cohort study was conducted. Patients were included as described in 
study population. Patient medical journals as well as PACS were scrutinized for 
information on magnitude and type of x-rays to which patients were exposed.  
Radiation dose in means of effective dose was calculated for all patients. For EOS and 
CR, reference values from study I was used. For the intraoperative CT scanner, the O-
arm, the radiation dose for 3D scans was calculated based on Dose Length Product 
(DLP) multiplied by conversion-factors. For the 2D fluoroscopy option of the O-arm,  
Dose Area Product (DAP) was used in conjunction with conversion factors to 
calculate effective dose.  
Both the radiation calculation for 3D and 2D were in accordance with The Danish 
National Board of Health, Institute of Radiation Protection(49). 
 
A survey study on trends in scoliotic management 
A questionnaire was sent out to nine international orthopedic spine centers. Each 
center with a background population of more than one million people. Questions were 
asked on treatment of idiopathic scoliosis and radiographic follow-up. Results were 
gathered and proportional relations were evaluated. 
Statistics 
Study I 
To model statistical data negative binomial regression was used. In order to bypass 
the need of multiple phantom dosimetry, Bootstrap statistics(50) was used to gain 
valid 95% confidence intervals, by using random sampling and theoretical 
calculations of organ dose values to assign uncertainties.  
Study II and III 
For the comparison of variability from the mean, 95% confidence intervals were 
calculated as two times the standard deviation from the mean according to the ISO-
 48  
 
5725 standard. Correlations between study II and previously published data(26,35)  
were analyzed with Spearman’s rank coefficient at a significance level set at 0.05. 
Study IV 
Only basic descriptive analysis was used, illustrating mean and median values. 
Study V 
Analyses of the relationship between rotation of phantom, dose absorption and TLD 
placement was performed along with 95% confidence intervals. Among other 
methods, generalized mixed effect linear modelling(51,52) was used as described in 
study V. Simple mean values and confidence intervals were used for description of 
the TLD sensitivity evaluation. 
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Results 
 
Study I 
First reports on organ doses and effective dose from the EOS micro-dose protocol was 
reported. Full-spine phantom imaging was performed in a pediatric and an adolescent 
phantom with EOS micro-dose and EOS standard-dose protocols and CR is illustrated 
in figure 14.  
 
 
It was confirmed that one micro-dose full-spine scan, as claimed by EOS®-imaging, 
was less than one week of normal back-ground radiation from nature. The effective 
dose from one micro-dose scan ranged from 22-27 µSv depending on positioning and 
age, one week of mean worldwide natural background dose approx. 46 µSv(6). 
The dose reduction for micro-dose versus standard-dose protocol was approx. 6-fold 
The dose reduction for micro-dose versus CR was 5-fold for the pediatric phantom 
and 17-fold for the adolescent phantom. There was an increase of effective dose of  
38% when using the EOS standard-dose compared with in-house pediatric CR 
protocol. Most organ doses were lower in EOS PAL positioning, by approx. 21%, and 
Figure 14 (study I(81)) 
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a 29% reduction of mean breast dose. Mean dose to the left breast was reduced 5.5-
fold from 403 µSv to 73 µSv, mean organ dose to the right breast was increased by 
33%. A few organs received a higher dose in PA. For instance, liver dose was 
increased by 22% (258 µSv versus 211 µSv ) for the adolescent phantom and liver 
dose was increased by 76% (230 µSv versus 131 µSv )for the pediatric phantom. 
 
Studies II and III 
Based on semi-quantitative image analyses of phantom images and subsequent in vivo 
pilot imaging, two dose-optimized protocols were established and clinically validated. 
Table 3 shows the comparison of doses between exposures of protocols. 
Table 3, Doses for default EOS scan protocols and the two optimized protocols of 
studies II and III 
Protocol Nano-dose Reduced Micro-dose Micro-dose Standard-dose 
DAP* 
mGy.cm2 
16 41 97 593 
*Dose Area Product for the pediatric phantom 
Study II 
The reduced micro-dose protocol established for 3D reconstruction, yielded less than 
half that of already validated micro-dose protocol, and more than 10-fold less than the 
standard-dose protocol. 15 children with a mean age of 11 years(8-12) were included. 
A total of 180 3D reconstructions were performed by the three operators. Intra- and 
inter observer reliability was comparable and in many ways as good as already 
validated micro-dose for 3D reconstruction. In table 4 some of the results of the 3D  
 
Table 4, Inter-operator 
reproducibility, 
variations from the mean 
(Presented at ICEOS 
2017, San Diego CA) 
 51  
 
reconstructions have been listed and compared with previous studies. The average 
duration of one 3D reconstruction was approx. 9 minutes (range 6-21). 
Study III 
A cohort of 23 consecutive children was included and underwent full-spine biplanar 
imaging with micro-dose and nano-dose protocols. Mean age was 11 years (9-12). 
Dose reduction of the nano-dose protocol was as illustrated in table 4, 37-fold reduced 
compared with standard dose and 6-fold reduced compared with micro-dose protocol. 
A total of 630 Cobb angle measurements were performed over a time span of two 
weeks. Reproducibility for both protocols was good. The Bland Altman plot 
illustrated a variation from the mean within internationally accepted standards of ≤5 
degrees of deviation from the mean, figures 15 and 16. Results for the nano-dose 
protocol were not significantly inferior to the micro-dose protocol.  
  
 
Study IV 
 
An overview of total accumulated full-body absorbed radiation dose for the scoliosis 
patients who were at some point of their treatment and radiographic follow-up at 
Aalborg University hospital in the years 2013-2016. The impact and differences of 
different radiographic systems are shown in table 5. 
The patients who received one or two ancillary CT scans (eg. Control, PET-CT, etc) 
had their cumulative absorbed radiation from all causes doubled.  
Intraoperative accumulated radiation dose could be as low as a total of 1.393mSv, for 
2 low-dose O-arm, intraoperative scans of 70kV/20mA (each scan 0.461mSv) and 26 
seconds of 2D O-arm fluoroscopy (0.427mSv). The highest accumulated 
intraoperative dose for one patient was 12.297mSv. The result of three high dose 
Figures 15 and 16. Interobserver reproducability of Cobb angle measurements 
for Nano-dose and Micro-dose protocols.(study III) 
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default intraoperative scans of 120kV/40mA (each scan 3.319mSv) and 58 seconds of 
2D fluoroscopy (2.338mSv). 
Table 5, Radiation exposure (Study IV) 
 Conservative group1 
(Median and range) 
Surgery group 
(Median and range) 
Conventional spine  
X-rays (CR) number2 / 
radiation dose 
4 (0-20)/1.1mSv(0-5.5) 14.5 (2-57)/4.1mSv(0.6-15.5) 
Biplanar EOS imaging 
Number2 / radiation dose 
2 (0-17)/ 0.58mSv(0-2.4) 10.5 (0-26)/ 1.3mSv(0-3.1) 
O-arm 3d scans 
Number/ dose 
 
 2(1-4)/ 3.8mSv(0.9-10.0) 
O-arm 2D fluoroscopy 
time in seconds/ dose 
 33.7(20.3-136.0)/ 0.9mSv(0.4-3.5) 
Radiation dose combined 
(CR, EOS, O-arm)  
1.1mSv(0.2-7.2) 10.3mSv(3.8-20.4) 
   
Additional CT and  
PET-CT3 
0 1(1-2) 
Radiation dose 0 11.9mSv(0.6-20.1) 
 
 
Total radiation dose all 
modalities 
1.1mSv(0.2-7.2) 10.8mSv(3.8-35.9) 
1Braced and observational 
2Total number of coronal and lateral images 
3A total of 6 patients had additional imaging owing to various reasons explained in the results section. 
 
 
The lowest radiation dose exposure observed for a posterior spinal fusion (PSF) of 10  
levels comprising 2 low-dose scans of each 0.461mSv, and 26 seconds of 
intraoperative fluoroscopy, was 1.393mSv. The highest intraoperative exposure 
during one PSF of 11 levels was almost 10- fold higher comprising 3 high-dose scans 
of each 3.319mSv and a total of 58 seconds of fluoroscopy. The patient receiving the 
highest dose of Intraoperative fluoroscopy from one intraoperative procedure received 
(2.425mSv) from 88 seconds. The Scan dose for this patient was 4.600mSv from 1 
high-dose scan and one low-dose scan.  
Study V 
At 21 different occasions, a total of 105 EOS standard-dose scans in PA, were 
performed on a female anthropomorphic phantom in order to evaluate absorbed liver 
mean organ dose. No statistical significant differences of mean organ doses were 
observed as illustrated in Figure 17. 
 53  
 
 
Table 6 illustrates the inverse relationship between rising numbers of TLDs in 
susbsets smaller than the total of 28 possible TLD locations (used to calculate the 
“true” mean organ dose) and the probability of reaching an acceptable combination 
by chance only.  
 
Figure 17(study V). Distribution of absorbed liver organ dose for three different 
axial rotational as well as liver doses previously measured and published by same 
authors(81)( Study I).  
Table 6(study V) 
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For the for subsets of 5-6 TLDs picked by logical symmetrical selection mean organ 
dose values were within 95% CI of “true” organ dose in 23 out of 24 cases. 
TLD tablet sensitivity decreased by almost 11% over the 21 radiation cycles of each 
five scans. Figure 18 shows the decline in sensitivity over time for measured reference 
doses prior to phantom imaging.   
 
 
No decrease in measured mean liver organ dose within each group of the three axial 
positions comprising 7 out of 21 organ dose measurements was observed (all TLDs 
were calibrated against reference doses chronologically and measured prior to 
installment and dose exposure in the phantom) 
Figure 18 (Study V) 
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Discussion 
The aim of this thesis was to provide novel information on the EOS scanner, reproduce 
and further develop previously reported methods and compare our results (study I) 
with published data. An investigation into establishing even more reduced-dose 
protocols with the EOS and the clinical validation of these was undertaken (Studies II 
and III). A total overview of accumulated dose to IS patients treated at our institution 
and a comparison with a number of international spine centers and current consensus 
guidelines for radiographic follow-up was performed (study IV). An investigation of 
how to optimize time spent on reliable phantom dosimetry was performed (study V). 
The combination of the above studies founded the basis for an evaluation and 
quantification of absorbed radiation dose and associated risk to the human body in 
relation to spinal imaging using ionizing radiation and ways to influence this by means 
of dose optimization. 
Dose optimization 
As described throughout this thesis, there are many ways to reduce radiation dose to 
patients. The most simple way is to eliminate exposure or reduce the number of x-
rays. In order to do so it is necessary to know what is the exact need of a particular 
investigation, is it indeed needed, and secondly how often is it needed. This of course 
depends on the natural course of a given disease and differs from one disorder to 
another, and from one patient to another. In studies I-IV different reduced dose 
protocols were evaluated.  
Study I 
Main findings 
The main findings of study I included a first phantom based organ dose and effective 
dose evaluation of the commercially available and clinically validated micro-dose 
protocol(26,41). An approx. 6-fold reduction of dose compared with the EOS 
standard-dose protocol was documented, and manufacturer claims of radiation dose 
exposure of less than one week of natural background-dose from one full-spine 
biplanar scan were verified. Results on micro-dose exposure were in line with other 
reports based on skin entrance dose and mathematical phantoms(26,53,54). However, 
the results of an award winning paper of Hui et al(39) were not in line with these 
results. We redid their calculations  and recognized a methodological error resulting 
in a supplementary addendum to their paper(55).  
Results of organ doses and effective doses using standard-dose protocol were 
comparable with previous reports based on  phantom dosimetry  and computerized 
models(24,40,42,43).  
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When comparing EOS standard-dose with CR for the adolescent phantom an expected 
dose reduction of more than 50% was observed. Unexpectedly, we found a 38% 
increase of total absorbed dose for the 5 year-old phantom. The reason for this was 
speculated to be a combination of optimized CR equipment in combination with a 
low-dose scoliosis protocol for the CR system. Renewed CR exposures and 
measurements of effective dose for the pediatric phantom yielded same results. One 
study of effective dose from CR for full-spine imaging reported similar results for 5 
to 7 –year old children(27).  
Both for the adolescent phantom and the pediatric phantom effective doses from CR 
were lower than diagnostic reference levels (DRLs) generally listed as 1-3.5 
mSv(26,56–58). However, other authors(13,24,40) found very similar results for full-
spine imaging of adults. When reporting on dose differences between different 
modalities it is crucial to be sure to state exactly what is being reported. The 45-fold 
reduction of dose from micro-dose vs CR as reported by Ilharreborde et al(2016)(26) 
is true when comparing with reference levels of 3.5 mSv for AP and Lateral x-ray, but 
very different from the 0.40-0.55  mSv as measured in study I and other more recent 
studies(13,24,40,58). As long as there is no universal DRL, the different proportional 
relation from each paper must always be taken into consideration. 
Strengths and Limitations 
The method for measuring full-body absorbed dose in the phantoms was similar to the 
method used by Damet et al (2014)(40), however, in order to strengthen the validity 
of measurements we used all available dosimeter locations for dose assessment. 
Damet et al used less than 25% of available locations. The method was limited in 
study I by the low number of measurements done for each phantom position, thus, 
bootstrap statistics(50) was used to strengthen the validity of uncertainty intervals, 
expressed as 95% CI. Repeated measurements of mean liver organ dose were 
performed in study V, and dose values were found to be almost identical; 204µSv 
(95% CI: 173-238) vs 197µSv (95% CI: 169-232) in study V. The observations 
supported our assumptions of estimating correct uncertainty values when advanced 
bootstrapping was used. 
Conclusion and clinical context  
As a conclusion study I corroborated the fact that micro-dose protocol is currently the 
commercially available full-spine x-ray protocol exposing patients to the least amount 
of radiation. This is well in line with the current efforts to develop safe and precise 
diagnostic modalities to our patients. Patients and clinicians can be reassured that 
undergoing micro-dose full-spine radiographic assessment poses no proven risk and 
is no different from a few days of natural background radiation. 
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Studies II and III 
Even with the EOS micro-dose being the most low dose option for full-spine 
radiography, still no lower level for which radiation dose could be harmful to the body 
has been defined. The micro-dose protocol had previously been clinically validated 
for both standard 2D images and for 3D reconstruction(26,35,53,54,59,60), and the 
question was raised whether it would be possible to reduce dose even further and still 
produce reliable Cobb angle measurements as well as 3D reconstruction. Two reduced 
micro-dose protocols were established and prospectively clinically validated.  
Study II resulted in a clinically validated protocol for 3D reconstruction of the spine, 
with a dose reduction of 58% compared with micro-dose protocol.  
Study III resulted in a clinically validated “nano-dose” protocol for 2D Cobb angle 
measurements, exposing patients to 1/6th (a dose reduction of 83%) the dose of the 
micro-dose protocol. A dose less than one day of natural background radiation(6). The 
variability of interobserver and intraobserver of Cobb angle measurements were 
within previously published standards(61,62). 
Strengths and Limitations 
Both the reduced micro-dose (study II) as well as the micro-dose protocol were found 
to be inferior to standard dose for both 2D and 3D parameters as illustrated in study 
II. However, results for the new protocol showed that it was comparable to micro-
dose 3D reconstruction and better than micro-dose “fast 3D”(26) reconstruction and 
thus could replace the micro-dose protocol for standard monitoring and 3D 
reconstruction of patients with mild to moderate scoliosis. Standard dose would still 
be the choice for most precise reconstruction and for evaluation of 3D parameters 
preceding surgery.   
The nano-dose protocol was not significantly inferior to the micro-dose protocol for 
coronal plane Cobb angle measurements, with minimal variability from the mean as 
illustrated in the results. Similarly to the reduced micro-dose protocol of study II, the 
nano-dose protocol was clinically validated in a prospective manner. Five observers 
instead of usually two or three observers provided additional strength to the 
interobserver analysis.  
For both studies obese patients and patients with implants were excluded, and thus 
neither protocol was validated for these patients. The general population is getting 
increasingly obese, and reduced radiation doses and obesity often do not correlate 
well, which was observed during the validation process of study III. The relatively 
small number of patients in both studies (study II (15) and study III (21)) might lead 
to falsely reduced variability towards the mean. Seven out of 21 children in study III 
had a mean Cobb angle below 10 degrees, these were analyzed separately as it would 
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be expected that inter- and intraobserver variability of these patients would be lower 
than for actual scoliotic curves. 
There seems to be no reason why not to apply these protocols in cases where micro-
dose generally applies, for 3D reconstruction of the spine or coronal plane Cobb angle 
assessment. Patients and just as important parents of children to be examined can rest 
assured that the potential harm from these protocols is close to zero.  
 
Conclusions and Clinical Context 
Reducing the amount of radiation dose is possible as shown in studies II and III. 
Results of both reduced micro-dose protocols were comparable to previously 
published standards for conventional radiology as well as micro-dose protocol,  
readily applicable to existing systems and ready for use in non-obese patients.  
 
Study IV 
An overview of the magnitude of cumulative dose from ionizing radiation in patients 
treated for IS at our institution was performed. As expected patients who underwent 
surgery received much higher cumulative doses than those treated conservatively. 
This study was the first study to  report total cumulative doses from all modalities 
including: CR, EOS, intraoperative CT and fluoroscopy as well as ancillary CT scans. 
The magnitude of  x-ray examinations was comparable to 
literature(13,16,17,28,29,63). Dose evaluations confirmed the theoretical reduction of 
doses when using EOS for monitoring, as well as reduced dose protocols for 
intraoperative CT scans for navigation. Just one ancillary CT scan was found to 
increase total absorbed radiation dose two-fold, reminding us of the importance of the 
right indication and the impact of such examinations.  
Results of a survey forwarded to 9 international high-volume spine centers showed 
trends of treatment and radiographic follow-up. There was no strict adherence to 
published international guidelines(20,64,65). Reasons for not adhering to consensus 
guidelines are various, and could be the result of clinical setup, habits, ignorance or 
possibly a lack of confidence in the correctness of outlined standards.   For patients 
with scoliotic disorders the effort of  Establishing and updating international 
guidelines for the use of radiographic follow up for patients with scoliosis is an 
ongoing process. By Introducing international standards for radiographic follow-up, 
the risk of every center making up their own clinical practice and potentially exposing 
patients to unnecessary imaging is restricted. However, one has to remember that 
 59  
 
consensus reports are based on expert opinions and not always hard evidence and need 
to be continuously updated along with the development of equipment and procedures.  
 
Strengths and Limitations 
The quantification of exposure was reported as both absorbed dose, and  numbers and 
types radiographic procedures for CR, EOS, O-arm CT and ancillary CT. This allows 
for future research on the same topic to be compared with our results, even in the case 
of change of conversion factors, tissue weighting factors or the case of different DRLs, 
etc.  The limited size of the historic cohort of patients studied did not allow for 
statistical analysis of possible correlations. 
Conclusion and Clinical Context 
When adhering to clinically validated low-dose protocols and consensus guidelines 
for radiographic monitoring and perioperative imaging, radiation dose can be kept 
low. In fact the total cumulative dose from repeated full-spine follow-up EOS imaging 
using standard dose for semiannual imaging for 10 years and 2 low-dose 
intraoperative CT scans, as defined by Petersen et al (2012)(66) will amount to 
approx. 3-4 mSv, not much different from one year of natural background radiation. 
Study V 
Results of study V showed that mean liver doses and uncertainties in AP positioning 
corresponded very well with the results of study I (figures 1.X and 5.1), and thus 
supported the assumptions made on uncertainties using bootstrap statistics previously 
in study I.  
The results of study V showed that handling time of liver organ dose measurements 
can be reduced by at least 75%, compared with full organ dosimetry, without 
compromising certainty of results. Damet et al (2014-2018)(40,67,68) used only a 
fraction (<25%) of available dosimeters in their studies of the EOS and O-arm 
investigating organ doses and effective doses based on anthropomorphic phantom 
dosimetry. For instance, for liver organ dose measurements only 2 to 5 out of 28 
possible locations were used. The authors did not state how this number of dosimeters 
was chosen, or which considerations were made before choosing specific locations 
for dosimeters. However, the probability that their measurements were significantly 
different from the “true mean” of all 28 dosimeters is likely, according to study V. 
To our knowledge, study V is the only study to have conducted repeated 
measurements with the same TLDs in the same locations for anthropomorphic 
phantom dosimetry over time. During the course of repeated radiation cycles from 1 
to 21, the mean sensitivity of the dosimeters dropped by almost 11%, corresponding 
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with findings of Poirier et al(69). This did not affect the reliability of measurements 
significantly, but showed the importance of continuous calibration of TLDs before 
dose measurements, and the importance of not to mix batches of TLDs. The exact 
reason for this drop of sensitivity is not known, but several causes have been discussed 
previously(69–71), and has been listed in study V. 
 
Strength, limitations and considerations of design 
The path to reaching the correct statistical analysis and methods for study V was 
challenging and time consuming. We did test if empirically chosen subsets could 
reach correct mean dose. Dose means from subsets of TLDs placed logically in 
relation to the particular x-ray source were compared with total dose mean and 
reached an acceptable result, as was in fact shown by “empirical selection” of subsets 
in study V. However, this method would not have had the same statistical strength 
unless for instance a large number of independently chosen subsets were applied by 
preferably more than one observer as an interobserver study.    
The results on reduced handling time and possibility of applying less TLDs when 
performing dosimetry applies to a particular ATOM dosimetry phantom used in a 
particular EOS scanner, and the direction of incoming x-rays specific to the EOS 
scanner. However, the statistical model using the same phantom or other phantoms 
can be applied to other x-ray modalities.  
Future work and clinical implications  
The method used in study V provides a tool at hand for future investigators in the field 
of organ dosimetry, and the option to apply this approach for future research and 
development is present. 
  
 
 
 
 
Confounding and limiting factors of dose absorption and causality 
We still do not know the most precise ways of obtaining dose estimates from absorbed 
radiation dose from within the body. Neither do we have a full understanding of the 
implications of dose magnitude and distribution within the tissues of the human body. 
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Dosimetry is often problematic or impossible especially when internal dosimetry is 
considered. Methods are not always intercomparable, owing to a number of reasons 
such as different methodology, imprecise measurements, etc.  
The presence of different noxas from the surrounding environment or in relation to 
occupational exposure, or life style factors such as smoking and drinking influence 
the risk of protracting cancer and might act as confounders when trying to evaluate 
the risk from  radiation itself. Unknown epigenetic factors, the presence of 
predisposing disorders or disease entities as mentioned by Oakley et al (30), might 
again pose further risk of confounding. An example of this could be the correlation 
between the  increased mortality from breast cancer and the number of x-rays to which 
patients were subjected in the studies of Ronckers et al (16,72)and Simony et al(17). 
We don’t know if there might be a higher prevalence of breast cancer among scoliotic 
females exposed to x-rays as a consequence of their underlying disease entity 
compared with the background population. 
Large prospective studies are to be undertaken in order to find a clear causality 
between low-dose radiation and the risk of cancer. The difficulty in finding correct 
suitable controls and monitoring of exposed population would pose great challenges. 
The fact that the lifetime risk of dying from cancer has been estimated to approx. 20-
30% makes it difficult to detect a potential increased risk of 0.17% from a dose of 10 
mSv(73). Thus, it remains very difficult to prove a specific pathology to be caused by 
radiation as many diseases are already relatively common.  
 
Dose optimization controversies and risk evaluation 
Risk calculations on the adverse effects of radiation are calculated based on “black 
boxes” as a lot of information is indeed not accessible. Epidemiologic data from 
historic cohorts such as the atom bomb survivor studies(9,10,74,75) and cohorts of 
patients followed over time support the fact that there is a correlation between the 
magnitude of absorbed radiation dose and the risk of detrimental effects. The risk 
estimates in this thesis are based on effective dose and the assumption of direct 
proportionality of absorbed dose and the resulting risk of detrimental effects in 
accordance with the LNT and the recommendations of the ICRP(2).  
Not everyone agrees with the assumptions of the direct proportional relationship 
between doses and risk and the extrapolation to include very doses and no lower dose 
threshold. Some contenders of the LNT, argue that there is no risk when exposed to 
occasional full-spine images, since the doses are way below any dose ever proven to 
cause harm and that the body’s own repair mechanisms will have repaired any 
radiation induced cell damage before the individual being subjected to new low dose 
radiation(30,76,77).   
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The whole issue of risk of risk from low dose radiation and dose optimization is an 
ongoing topic of big dispute(12,30,73,77–79). So, are we hunting ghosts when trying 
to dose optimize and avoid potential radiation induced cancers? Siegel et al(77) 
believe so. They claim that the greatest risks to patients are posed by doctors striving 
to reduce dose, while risking to provide patients with inadequate imaging, thus 
possibly missing important pathological signs and diagnoses. The same authors, 
however, state that care must be taken to avoid unnecessary radiation!  
Even though, the LNT has been disputed and questioned in recent times, there is so 
far no viable alternative to this model(73), and it is still recommended by the ICRP, 
UNSCEAR, IAEA and NCRP. It is out of the scope of this thesis to decide for or 
against the model for estimation of risk as a result of low dose radiation. Still, as of 
today there is no known lower threshold of dose which might potentially cause cancer, 
and until this is proven, we have be considerate and avoid all unnecessary radiation 
exposure to our patients. It is the obligation of all researchers and clinicians to be 
aware of the potential risk from radiation, to be prudent, appreciate precaution and act 
as per the ALARA principle as long as we have no clear evidence for or against the 
risk posed by the ionized radiation used in medical imaging and treatment. 
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Conclusion 
The aims of the overall thesis were met. A thorough investigation into the current dose 
exposure from the EOS low-dose scanner was conducted, and methods to reduce 
radiation dose even further were established and clinically validated. Results of 
exposure from micro-dose protocol as well as exposure from reduced dose protocols 
relayed novel information and underlined the very low dose subjected to patients from 
these modalities. The methods used for estimation of dose and levels of uncertainty 
were confirmed within the studies and when compared with literature. An evaluation 
of absorbed radiation dose from all x-ray modalities used at our department for the 
treatment of scoliosis was conducted. This evaluation illustrated the dispersal of 
radiation dose amongst patients treated for idiopathic scoliosis, allowing us to 
estimate risks from ionizing radiation for this group of patients. A method was 
proposed to reduce time spent on organ  dosimetry without compromising certainty 
of organ dose estimations.  
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Suggestions for Future Research 
The studies of this thesis have been conducted in a manner of transparency allowing 
for other researchers to scrutinize results and methods, and if needed the reproduction 
of studies.  
Currently a strategy of how to implement one or both reduced-dose protocols is being 
worked out at our institution. A prospective study evaluating the future results of these 
protocols would be mandatory. Research into to the challenges of the increasing 
obesity of the population and consequences for image quality and absorbed dose 
would be areas of interest. 
Tools and methods for reducing time on organ and whole body dosimetry were 
presented for one organ. Future studies applying same or similar methods to other 
organs or all organs of anthropomorphic phantoms are imminent. 
We have evaluated both individual organ dose and full body absorbed doses. Future 
research areas  of interest is the correlation between specific dose  to one organ in 
relation to full-body absorbed dose. 
Risk was assessed in terms of effective dose. A different way of evaluating risk from 
ionizing radiation could be contemplated to be in terms of years potentially lost life 
(YPLL). YPLL is another way to evaluate the risk of dying from radiologically 
induced cancer. Based on the principles of study IV a study describing the 
consequences of continuous radiological examinations in spine patients in terms of 
YPLL could be proposed.  
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Abstract
Purpose The aim of this study was to validate the reproducibility of 3D reconstructions of the spine using a new reduced micro-
dose protocol.
Methods First, semi-quantitative image analysis was performed using an anthropomorphic child phantom undergoing low-dose
biplanar radiography. This analysis was used to establish a “lowest dose” allowing for acceptable visibility of spinal landmarks.
Subsequently, a group of 18 scoliotic children, 12 years of age or younger, underwent full-spine biplanar radiography with both
micro-dose and the newly defined reduced micro-dose. An intra- and inter-observer reliability study of 3D reconstructions of the spine
was performed according to the International Organization for Standardization (ISO)-5725 standard, with three operators.
Results The reduced micro-dose setting corresponded to a theoretical reduction of radiation dose exposure of approximately
58%. In vivo results showed acceptable intra- and inter-observer reliability (for instance, 3.8° uncertainty on Cobb angle),
comparable to previous studies on 3D spine reconstruction reliability and reproducibility based on stereo-radiography.
Conclusion A new reduced micro-dose protocol offered reliable 3D reconstructions of the spine in patients with mild scoliosis.
However, the quality of 3D reconstructions from both reduced micro-dose and micro-dose was inferior to standard-dose protocol
on most parameters. Standard-dose protocol remains the option of choice for most accurate assessment and 3D reconstruction of
the spine. Still, this new protocol offers a preliminary screening option and a follow-up tool for children with mild scoliosis
yielding extremely low radiation and could replace micro-dose protocol for these patients.
Key Points
• We investigated the reliability of 3D reconstructions of the spine based on a new stereo-radiography protocol reducing
radiation dose by 58% compared with established micro-dose imaging protocol.
• The new reducedmicro-dose protocol offers a reproducible preliminary screening option and a follow-up tool in the necessarily
frequent repeat imaging of children with mild scoliosis yielding extremely low radiation and could replace existing micro-dose
protocol for these patients.
• EOS standard-dose protocol remains the option of choice for exact radiographic assessment of scoliosis, offering more exact
3D reproducibility of the spine compared to both micro-dose and the new reduced micro-dose protocols.
Keywords Three-dimensional imaging . Scoliosis . Radiation dosage . Radiography . Reproducibility of results
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Abbreviations
AIS Adolescent idiopathic scoliosis
ALARA As low as reasonable achievable
AVR Apical vertebra rotation
DAP Dose area product
IAR Intra vertebral rotation
ISO International organization for standardization
PAL Posterior-anterior-lateral positioning
PT Pelvic tilt
TI Torsional index of the spine
Introduction
The evaluation of 3D spine deformity in scoliosis is challeng-
ing and optimally requires comprehension and use of 3D clin-
ical parameters [1, 2]. The correct interpretation of spinal de-
formities is mandatory to define the optimal treatment strategy
for the patients. Different methods for 3D evaluations have
been used and evaluated [3], and reconstruction based on
stereo-radiography is a commonly used method. Several stud-
ies have investigated the possibility of predicting progression
of scoliosis based on 3D parameters [1, 2, 4–6], since
predicting scoliosis progression at an early stage would be of
paramount importance. Apical vertebra rotation (AVR), tor-
sional index of the spine (TI), and intra-vertebral rotation
(IAR) have been proven significant parameters in determining
progression in mild scoliosis (Cobb angle < 25° [2, 4]). In the
recent 20 years, a lot of effort has gone into defining the “gold
standard” for 3D parameters, and to apply these for effective
and easy-to-use tools in daily clinical life [3].
The repeated use of X-ray imaging needed for scoliotic
patient follow-up has been of concern in recent years.
Ionizing radiation has been associated with a potential risk
of developing radiation-induced cancer in scoliotic patients
[7–10]. Children have a long life expectancy and are thought
to be especially sensitive to long-term stochastic effects from
ionizing radiation. Thus, it is of great importance taking steps
towards using methods reducing the radiation exposure to our
patients. The best approach of course would be to define ro-
bust methods of early detection of progressive scoliosis and
more efficient methods of treatment in order to limit the num-
ber of radiographic exams needed for follow-up. However,
although promising results have been reported in the literature,
such methods are still not validated or widespread [4, 6, 11].
The second-best approach is to reduce the ionizing radiation
delivered by the radiological exam.
EOS® low-dose stereo-radiography (EOS Imaging) is an
imaging system that allows for high-quality imaging at a ra-
diation dose lower than most conventional systems [5, 8, 12],
adhering to the ALARA dose-optimization principle of keep-
ing dose as low as reasonably achievable [13]. 3D reconstruc-
tion fromEOS imaging stereo-radiography has been described
in several previous studies [4, 14–17]. Good reliability on 3D
parameters has been reported for both standard-dose and
micro-dose protocols [14, 15, 17]. Ilharreborde et al [15, 17]
looked at both standard-dose and micro-dose protocols with
regard to intra- and inter-observer reproducibility. Results
were satisfactory for both modalities and a significant reduc-
tion of dose compared with the original standard-dose proto-
col was described. We hypothesized that the radiation dose
delivered to the patient could be reduced even further without
compromising reliability of 3D reconstructions. The aim of
the present study was to investigate the possibility of reducing
the dose of the established micro-dose protocol retaining the
possibility of trustworthy 3D reconstructions from the EOS
imaging stereo-radiography.
Materials and methods
Defining the reduced micro-dose protocol
The minimal dose judged to yield sufficient image quality for
recognition of anatomical landmarks was defined by imaging
a clinically validated ATOM dosimetry child phantom (CIRS,
Computerized Imaging Reference System, Inc.) [18]. Figure 1
shows the phantom in posterior-anterior-lateral (PAL) posi-
tioning within an EOS scanner. Radiographic expositions
were made with sequentially lower dose settings. Radiation
dose exposure from the EOSmicro-dose protocol was reduced
by decreasing the current, milliamps (mA), and the scan
speed. Both parameters are directly proportional to radiation
dose: a 25% decrease of mA reduces exposure by 25%. A
change of scan speed from speed 4 to speed 3 likewise results
in a reduction of radiation dose by 25%. An experienced sur-
geon rated image quality with a semi-quantitative approach:
phantom images were cut in regions of interest (lumbar, tho-
racic and full body, in frontal and lateral views) and
anonymized, so the surgeon could blindly grade them, in a
random order of region and quality. A score from 1 to 5 was
assigned to each image by the surgeon (1 = optimal, 5 =
unacceptable), and all images were scored twice. A cumula-
tive score was calculated for each dose and plotted against
dose. A sharp increase of image quality was noticed at
28 mGy.cm2 (50 mA and 60 kV for frontal imaging and
50 mA and 80 kV for lateral imaging, with a scan speed of
2): although the score increase was not statistically significant,
this cutoff value was chosen. Preliminary in vivo measure-
ment confirmed the readability of the X-rays with these
settings.
Theoretic dose reductions were calculated from proportion-
al differences of dose area product (DAP) values between the
standard-dose, micro-dose, and reduced micro-dose protocols
(Table 1).
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Inclusions
The local ethics review board approved of the study design
and methods. A consecutive group of 18 children, 12 years of
age or younger, planned for routine clinical and radiological
investigation of scoliosis were offered micro-dose and re-
duced micro-dose images instead of one standard-dose image.
An informed consent was obtained for each patient prior to
imaging. Images with both protocols were obtained at the
same radiological session, one after the other, no more than
2 min apart. This method allowed for direct comparison of 3D
parameter reproducibility between the two modalities.
Exclusion criteria were severe obesity, previous spine surgery
with implants, and mal-positioning of the patients.
3D reconstructions
A validated method of 3D reconstruction of the spine from
EOS 2D biplane images was used [14]. Patient data and ac-
quisition settings were blinded and reconstructions took place
in random order. Three operators, all trained within 3D recon-
structions, did two reconstructions for each obtained image.
One operator determined, for each patient, the levels of
junctional and apical vertebrae for each scoliotic curve.
Table 2 lists the 3D parameters investigated. Figure 2 illus-
trates 3D reconstruction images using the reduced micro-dose
protocol.
Statistics
Intra- and inter-operator reproducibility were determined ac-
cording to the ISO 5725-2:1994 standard, in terms of standard
deviation. Bland-Altman plots were used to observe measure-
ment agreement. Results were compared with previously pub-
lished data on 3D reconstruction based on stereo-radiography
and micro-dose [14, 17]. Correlations were analyzed with
Spearman’s rank coefficient; significance was set at 0.05.
Results
The reduced micro-dose protocol corresponds to a theoretical
reduction of radiation exposure of approximately 58% and
93% compared with micro-dose and standard-dose protocols,
respectively. Table 1 shows the three scan settings and DAP
values for the child phantom.
Preliminary in vivo images with the new reduced micro-
dose setting allowed sufficient quality for 3D reconstruction.
Fig. 1 The anthropomorphic phantom, representing a 5-year-old child,
placed in posterior-anterior-lateral positioning within the EOS scanner
Table 1 Scan protocols and resulting DAP values for the 5-year-old
anthropomorphic phantom
EOS scan protocols
Protocols Reduced micro-dose Micro-dose Standard-dose
Morphotype Small Small Small
Scan speed 2 3 4
Anterior X-ray tube
kVa 60 60 83
mAb 50 80 200
DAPc (mGy.cm2) 13 30 222
Lateral X-ray tube
kV 80 80 102
mA 50 80 200
DAP (mGy.cm2) 28 67 371
Total DAP values
(mGy.cm2)d
41 97 593
Radiographic exposures undertaken with posterior-anterior-lateral stereo-
graphic biplanar imaging
aKilovolts
bMilliamps
cDAP = dose area product for a child phantom representing a 5-year-old
at phantom height of 72 cm
dAnterior + lateral DAP values
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Figure 3 illustrates an example of micro-dose and reduced
micro-dose full-spine imaging.
A group of 18 consecutive children going for routine clin-
ical investigation for scoliosis were then assessed with both
micro-dose and reduced micro-dose imaging. Three children
were excluded; two were carrying braces during imaging, one
had an abnormal number of vertebrae (14 thoracic vertebrae).
The remaining 15 children were included in the study. The
mean age was 10.7 years (range 4–12), gender distribution
amongst the included patients: four males and 11 females.
Mean reconstruction time was 10 min (range 6–21 min) for
the micro-dose and 9 min (range 5–16 min) for the reduced
micro-dose. Reconstruction time was not correlated with
Cobb angle (i.e., with scoliosis severity, p > 0.05).
Reproducibility
A total of 180 3D reconstructions were made (15 patients × 2
modalities × 3 operators × 2 occurrences). 3D reconstructions
were possible for all patients, and key anatomical landmarks
needed for 3D reconstructions were visible for patients in both
protocols. However, for both protocols, mostly the reduced
micro-dose group, spinous processes were in some cases
Fig. 2 Examples of 3D
reconstruction from reduced
micro-dose protocol, coronal and
lateral views
Table 2 The different 3D parameters investigated
3D parameters investigated
3D parameters Cobb angle T1-T12 kyphosis T4-T12 kyphosis L1-S1 lordosis AVR TI Pelvic incidence Sacral slope Pelvic tilt
AVR apical vertebra rotation, TI torsional index of the spine
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difficult to visualize because of increased vertebral rotation.
Other anatomical landmarks such as vertebral endplates and
pedicles were not affected to the same degree. Tables 3 and 4
show results on 3D repeatability and reproducibility along
with results from previously published papers. Both micro-
dose and reduced micro-dose showed good reproducibility;
however, 3D reconstruction from standard-dose as demon-
strated by Humbert et al 2009 [14] remained superior.
Reproducibility between micro-dose and reduced micro-dose
within this study was better for the micro-dose protocol. The
highest degree of variability was on AVR and kyphosis pa-
rameters. Table 4 shows that reduced micro-dose was better
Fig. 3 a Coronal full-spine image
in EOS scanner using micro-dose
protocol. b Coronal full-spine
image in EOS scanner using
reduced micro-dose protocol
Table 3 Intra-operator repeatability of clinical parameters, in terms of standard deviation of uncertainty, obtained in the current study and compared
with existing literature. All parameters are expressed in degrees
Intra-operator repeatability, variability from the mean
Studies, mean Cobb angle Protocol Main Cobb
angle
T1-T12
kyphosis
T4-T12
kyphosis
L1-S
lordosis
AVR Torsion Pelvic
incidence
Sacral
slope
Pelvic
tilt
Current study 16.1° (range
0.2–39)
Reduced
micro-dose
4.3 5.3 4.7 4.6 4.7 4.7 4.3 3.2 2.6
Micro-dose 2.4 5.3 4.0 3.5 5.3 3.5 3.1 2.6 2.7
Ilharreborde et al 2016 Micro-dose 3.6 4.8 4.5 5.8 – – 5.2 5.2 1.3
24.8° (range 4.6–64.7)
Ilharreborde et al 2011
62° ± 11*
Standard-dose 4.8 5.9 4.4 5.1 5.3 – 4.6 4.3 1.0
*Standard deviation
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on all parameters except pelvic tilt (PT) and T4-T12 kyphosis,
compared with Ilharreborde et al (2016) [17] “fast-spine”
micro-dose reconstructions.
Discussion
The purpose of this study was to investigate and validate re-
producibility of 3D reconstruction of the spine from stereo-
radiography with a reduced micro-dose protocol in scoliotic
pediatric patients. For most 3D parameters in mild, reproduc-
ibility was comparable to previous studies [14, 15, 17]. As
expected, the reduced micro-dose protocol was less reliable
than standard-dose and micro-dose for some parameters. 3D
transverse rotational parameter uncertainty, AVR and torsion,
was higher in this study on both reduced micro-dose and
micro-dose protocols than the reported values from Humbert
et al (2009) [14] using standard-dose, as well as uncertainties
on Cobb angle and T4-T12 kyphosis (5.4° and 6.0° in reduced
micro-dose, respectively, versus 3.1° and 3.8° in the previous
work). However, the reproducibility obtained using reduced
micro-dose “full” 3D reconstruction was superior in all clini-
cal parameters except for PT to the results obtained using “fast
spine 5min process” (Ilharreborde 2016) using micro-dose in
patients with scoliosis severity comparable to this study. Thus,
the reduced micro-dose protocol offered acceptable 3D recon-
struction reliability of the spine in patients with mild scoliosis.
Depending on the objective of the exam, such reliability
would be fine for initial screening and follow-up of scoliosis.
Limitations
The definition of minimal dose was inherently subjective,
since only one surgeon was implicated in the semi-
quantitative definition of the cutoff dose, but efforts were
taken to make it as objectively as possible. Quantitative pa-
rameters to determine image quality were also tested (such as
signal-to-noise ratio), but they tended to vary linearly with
dose variations, showing no useful cutoff value. The semi-
quantitative approach utilized, on the other hand, implicitly
accounted for the visibility of the anatomical landmarks of
interest for the interpretation of the radiographic information
and it showed a cutoff value indicating that image interpreta-
tion below a certain radiation dose (28 mGy.cm2) would suffer
significantly.
A reduction of radiation dose exposure to the patients of
more than 50% could be beneficial to the patients reducing
potential harmful side effects to ionizing radiation considering
the ALARA principle. Still, the risk benefit balance needs to
always be evaluated according to the needs of a given radio-
logical assessment. Existing EOS standard-dose protocol al-
ready offers high-quality images suitable for 3D reconstruc-
tion of the spine at a low radiation dose, as shown by Humbert
et al [14]. For instance, the reduced micro-dose protocol
would not be accurate enough to calculate the severity index
of scoliosis progression [4] or simulate or plan surgery.
Moreover, the reliability might not be accurate enough for
research, where the development of algorithms and decision
trees needs higher accuracy. Images obtained with reduced
micro-dose were as expected of lower quality than standard-
dose andmicro-dose, i.e., more noisy and with less contrast. In
standard-dose and micro-dose, the spinous processes are often
difficult to visualize, which was generally worse for reduced
micro-dose. Spinous process location is, along with pedicles,
an important landmarks used to evaluate the axial orientation
of the vertebra. However, pedicles were sufficiently recogniz-
able in most patients, except one patient with severe kyphosis.
This was independent of the imaging dose as it is inherent to
the patient’s spinal geometry; this type of patient would also
have been challenging with other 2D modalities and does in
Table 4 Inter-operator reproducibility of clinical parameters, in terms of standard deviation of uncertainty, obtained in the current study and compared
with existing literature. All parameters are expressed in degrees
Inter-operator reproducibility, variability from the mean
Studies, mean Cobb angle Protocol Main Cobb
angle
T1-T12
kyphosis
T4-T12
kyphosis
L1-S
lordosis
AVR TI Pelvic
incidence
Sacral
slope
Pelvic
tilt
Current study 16.1°
(range 0.2–39)
Reduced
micro-dose
5.4 6.6 6.0 5.8 7.5 6.0 5.4 4.6 3.6
Micro-dose 3.8 6.6 4.6 5.1 6.6 4.8 3.7 3.7 2.7
Ilharreborde et al 2016 24.8°
(range 4.6–64.7)
Micro-dose 5.4 7.1 5.7 7.9 – – 7.8 7.0 1.9
Ilharreborde et al 2011
62° ± 11*
Standard-dose 6.2 7.0 5.7 5.9 6.1 – 4.7 4.3 1.4
Humbert et al 2009 Mild
scoliosis
Standard-dose 3.1 5.5 3.8 4.6 3.4 4.0 3.4 3.0 1.4
*Standard deviation
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fact put a restriction on usability of 3D reconstruction from
stereo-radiography. In some cases, regular CT should be ad-
vocated for.
For both modalities, T1, which is one of the landmarks
needed to initialize the 3D reconstruction, was not always
visible in lateral projection due to overlapping upper ex-
tremities/shoulders, although correct validated patient posi-
tioning was adopted in this work and patient mal-
positioning was the cause for exclusion. Nevertheless, sag-
ittal inclination of T1 can usually be inferred by the ori-
entations of the adjacent vertebrae. The same applies in
the mid-thoracic region where there is low visibility in the
lateral view because of the large body span traversed by
the X-rays.
As shown above, operator time is still a limiting factor
since the average 3D reconstruction time was 10 min, which
is often not compatible with everyday clinical routine. A new
and faster method is needed to benefit optimally from this 3D
analysis method, potentially automated, to reduce user depen-
dence [14, 15, 17]. We do not recommend this new protocol
for children with implants or wearing braces as these cases
were not yet investigated.
Conclusion
We propose a new reduced micro-dose protocol for 3D recon-
structions based on stereo-radiography which offers reliable
3D reconstructions for preliminary screening and follow-up in
children with mild scoliosis. However, standard-dose protocol
remains the option of choice for most accurate assessment and
3D reconstruction. The reduced micro-dose protocol is appli-
cable to existing EOS systems and can be taken into use for
children being assessed for mild scoliosis right away and
could replace micro-dose for these patients.
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EOS, O-arm, X-Ray; what is the cumulative radiation exposure 
during current scoliosis management? 
 
Ari Demirel, Peter Heide Pedersen, Søren Peter Eiskjær 
 
Abstract 
Introduction: 
Patients undergoing scoliosis management are exposed to repeated radiological 
imaging. Previous studies have shown an increase in incidence of cancer among these 
patients. The primary aim of this study was to evaluate the radiographic examinations 
and cumulative radiation dose to which scoliotic patients are exposed. Secondly, to 
compare in-house algorithms of scoliosis management and radiographic follow-up to 
international spine-centers  and current consensus literature.  
 
Materials and methods: A single-center retrospective review evaluating type 
and frequency of radiographic imaging and total cumulative radiation 
exposure to patients treated for scoliosis. Inclusions: patients followed for 
idiopathic scoliosis in the years 2013-2016. A survey asking for information 
on management and radiological follow-up algorithms  was sent to a number 
of international spine centers for comparison with in-house algorithm.  
Results: 
Patients who underwent surgery received an approximately 10-fold higher median 
cumulative radiation dose than those treated conservatively. Variety of radiological 
follow-up algorithms among 8 spine centers was observed.  
Conclusion:  
Cumulative radiation dose during scoliosis treatment varies substantially depending 
on radiographic follow-up protocol, intraoperative and ancillary imaging. By using 
low-dose x-ray systems in combination with low-dose protocol for intraoperative 
navigation it is possible to keep exposure to patients at a minimum, while still 
providing optimal care.  
Funding: No funding received 
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Introduction 
Scoliosis patients are exposed to repeated radiological imaging, during 
assessment, treatment and follow-up. Previous studies have shown a correlation 
between increased risk of cancer and exposure to ionizing radiation during 
scoliosis follow-up[1–3], especially an increase of breast cancer mortality has 
been of concern. In recent years much effort has gone into optimization of X-ray 
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equipment and imaging protocols in order to reduce exposure of ionizing radiation 
to our patients[4, 5]. As of today, there is no known lower limit of the amount of 
ionizing radiation which might lead to radiation-induced cancer and thus we have 
to limit the use of ionizing radiation, while maintaining adequate image quality 
for correct treatment of our patients. The primary aim of this study was to evaluate 
the frequency and type of radiographic examinations to which scoliotic patients 
are exposed at our institution and to estimate the total cumulative radiation dose 
to which a typical scoliotic patient is subjected. Secondly, a survey was sent out 
to nine international spine-centers asking for information on scoliosis assessment 
and follow-up in order to compare to our in-house algorithms and the current 
consensus literature. 
Methods 
A single center retrospective review of medical charts on patients treated 
for idiopathic scoliosis was performed. Ethical approval for the study was not needed 
according to the Regional Committee on Health Ethics, approval for establishing a 
data base was obtained according to Danish law. 
Inclusions: all patients aged 0-18 years of age, who were either treated 
surgically or conservatively, at our institution in the years 2013-2016. Braced 
patients and patients followed only by radiological observation of curve 
progression were gathered in the same group and termed conservative. Patients 
with neuromuscular disease or any type of severe syndromic disease were 
excluded. 
Medical records and the Picture Archiving and Communication System 
(PACS) were scrutinized to retrieve information on the number and types of 
radiographic imaging to which patients were subjected. Included were all imaging 
in relation to the assessment, follow-up and treatment of idiopathic scoliosis used 
at our institution. This included conventional digital full-spine scoliosis 
radiographs (CR), EOS® (EOS-imaging, Paris, France) low-dose full-spine stereo-
radiography and computerized tomography (CT), including both intraoperative 
navigation (O-arm
® 
Cone beam CT, Medtronic Inc.) and ancillary CT and PET-
CT. 
The numbers and projections of full-spine CR were registered as 
separate exposures, eg. coronal and lateral imaging of the spine was counted as 
two exposures. In the case of splicing/stitching of full-spine images, each 
separate exposure was counted. The same method was used to quantify the 
numbers and projections of EOS images. 
 
Estimation of cumulative radiation dose 
The total cumulative radiation dose to the scoliotic patients was estimated 
by calculating the theoretic amount of full-body absorbed radiation dose in terms of 
effective dose in millisieverts (mSv). In order to calculate the cumulative radiation 
dose from CR and EOS, the number of images divided by two (coronal and lateral 
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planes) were multiplied by effective dose references for CR-and EOS stereo-
radiography for full-spine examinations. The reference doses for full-spine 
examinations were estimated based on phantom dosimetry[6]. Reference doses: CR 
anterior-posterior-lateral (APL) projections (0.545 mSv) and EOS standard-dose 
APL projections (0.220 mSv) All doses had been calculated according to the 
International Commission of Radiologic Protection (ICRP), ICRP-103 approach[7]. 
Effective doses for the O-arm 3D cone beam CT scans and ancillary CT 
and PET-CT were calculated based on Dose Length Product (DLP) and CT 
conversion factors according to the Danish National Board of Health, Institute of 
Radiation Protection (SIS)[8]. Effective doses for intra- operative 2D fluoroscopy 
using the O-arm were calculated by using dose area product (DAP) values and x-
ray conversion factors according to the Danish National Board of Health, Institute 
of Radiation Protection (SIS). At our institution we routinely use low-dose 
intraoperative scan  protocol (70kVp/20mA) introduced by Petersen et al in 
2012[9], whereby CT dose from the O-arm was reduced by almost 90% compared 
with default protocol. 
Algorithms for scoliosis follow-up at our institution 
Follow-up for scoliosis at our institution comprises clinical 
examination and biplane full- spine imaging. Since the fall of 2014 EOS low-
dose stereo-radiography has been first choice for full-spine radiography, and 
CR biplane imaging solely used in cases where EOS was not available. Figure 
1, illustrates the EOS low-dose scanner, a system that has been described to 
markedly reduce radiation dose exposure to patients. The system has been 
described in detail previously(10). Figure 2, illustrates the follow-up and 
treatment algorithms at our institution. 
If brace treatment is initiated, the Charleston Nighttime bending brace 
(Charleston® bending brace, South Carolina, USA) is the treatment of choice. 
Postoperative radiographs are performed for all cases of scoliosis: before discharge 
from hospital and, at 6 months, 1 year and 2 years postoperatively.  
Consensus survey for scoliosis follow-up at international spine centers 
A survey was forwarded to nine international orthopedic spine centers, 
in Denmark, Norway, Sweden, Spain, UK, France and USA, dealing with the 
assessment and treatment of scoliosis, by using a web based survey tool (Survey 
Monkey, https://www.surveymonkey.com). All centers served a population 
larger than 1 million, four of these were high volume centers performing more 
than 100 surgeries for scoliosis per year. 
 The survey included questions about the practice of radiological follow-up of 
scoliotic patients to illustrate the similarities or differences among centers, and 
to compare the answers with current published international consensus 
guidelines[11–13]. The questionnaire used can be found at the following link: 
https://www.dropbox.com/s/mlladixj2dwy8bm/SurveyMonkey_160922409-
2.pdf?dl=0 
Results 
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Final inclusions 
Demographics for the 61 patients included in this study are shown in 
Table 1. Six patients underwent more than one surgery; three were managed 
initially with growing rod systems and secondly final correction surgery with 
posterior spinal fusion. Another three patients underwent additional revision 
surgeries; two cases owing to progression of curves adjacent to fusion, and one 
patient owing to implant failure (screw loosening and rod breakage). 
Radiological exposure 
Radiologic imaging and exposure has been expressed in terms of 
numbers of images and radiation dose (effective dose) to patients from all 
modalities during assessment, treatment and follow-up, Table 1. In 66%(73/111) 
of the intraoperative scans used for safe instrumentation, the O-arm low-dose 
protocol was used. Dose from a single low-dose scan of 70kVp/20mA was found 
to be 0.45mSv, comparatively a default scan of 120kVp/40mA was 4.02mSv. 
Patients who underwent surgery received an approximately 10-fold 
higher median cumulative radiation dose (excluding ancillary CT and PET-CT) 
than those treated conservatively. 
Ancillary radiological imaging, from CT and PET-CT, on average 
resulted in an approximate 100% increase of total dose from all routine imaging 
(CR, EOS and Intra-operative O- arm based navigation and fluoroscopy), Table 2. 
Approximately 25% (39.04mSv/161.82mSv) of total intraoperative 
radiation dose from the O-arm was a result of 2D fluoroscopy. 
Mean/median weight and height at time of surgery were 54.9/54kg 
(range 42-80) and 166.2/165cm (range147-184), values directly comparable to 
the female dosimetry phantom, from which the reference doses were estimated; 
weight 55 kg and height 160 cm[11]. 
Survey 
Eight out of nine international spine-centers, each serving a population 
size from 1 million to more than 10 million, answered our survey regarding 
treatment and radiological follow-up algorithms on patients with adolescent 
idiopathic scoliosis. The usual interval between preoperative imaging varied 
among the centers, half (3/6) of those who answered this question saw patients for 
radiographic controls every 3 months, the other half every 6 months. Surgically 
treated patients were seen anywhere from one to four times for radiographic 
follow-up over a period of time, ranging from 6 months to 2 years postoperatively. 
Five centers saw patients every six months after instituted brace treatment, three 
centers once every year. A variety of radiographic systems and techniques used at 
the different centers are shown in Table 3. 
Discussion 
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To the best of our knowledge, this retrospective study represents the first 
assessment of the cumulative radiation dose from CR, EOS stereo-radiography and 
the O-arm for a typical patient undergoing current management for idiopathic 
scoliosis. Patient demographics and magnitude of perioperative x- ray/EOS 
acquisitions were comparable to other studies[1,2,15–17], as well as the mean 
number of levels fused. 
Exposures and radiation dose 
As expected and previously shown by Presciutti et al[16], the patients who 
underwent surgery had substantially  more radiographic imaging than the 
conservative group, and thus received higher levels of absorbed radiation dose. The 
large difference in observed absorbed radiation dose among the two groups was 
mainly due to intraoperative imaging as well as ancillary imaging. Apart from this, 
the combined observation time for the conservative group was shorter, to some 
extent caused by the fact that a part of the conservative group was only assessed 
once or just a few times resulting in a low number of total follow-up images. 
Intraoperative imaging from O-arm CT and fluoroscopy made up roughly 
50% of the total amount of absorbed radiation dose in the surgical group. In the 
study by Presciutti et al[16] intraoperative imaging accounted for 78% of total 
accumulated dose. The reason for our percentage being lower may very well owe 
to the low-dose intraoperative scan protocols used at our institution. However, our 
intraoperative dose exposure would have been even lower if a higher degree of 
adherence to the low-dose protocol had been observed. 
The fact that just one ancillary CT or PET-CT resulted in a two-fold 
increase of total cumulative radiation dose is a very disturbing finding seen in 
relation to the overall dose assessment of these patients, and once again emphasizes 
the importance of keeping the number of CT scans at a bare minimum. 
Survey and consensus 
Our survey showed that most of the spine centers agreed on surgical 
technique and not to use post-operative CT. However, the survey also illustrated 
some of the discrepancies among different centers as for how often to assess and 
for how long to follow patients with idiopathic scoliosis, as well as choice of 
radiographic systems, Table 4. Roughly half of the centers used a follow-up 
algorithm similar to our algorithm which is in line with the consensus guidelines 
of Kleuver et al[11] and Knott et al[12].Implementation of international 
consensus guidelines on follow- up algorithms for scoliosis can be various 
depending on the department, local tradition, and depending on which consensus 
guideline was used. 
In fact, there is still a lack of clear international consensus as how often 
and how many x- rays are needed in course of scoliosis treatment. A review of 
recent literature does not give a clear picture of this[11–13,17]. There is agreement 
as to the needs of at least one coronal and lateral radiograph during or after surgery, 
but not as to the timing of subsequent follow-up intervals and for how long to 
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follow patients. 
Only one in eight used routine postoperative CT as well as one in eight 
using intraoperative navigation. We use intraoperative navigation at our institution 
for all scoliosis surgery, based on studies showing significantly less screw 
misplacements than freehand technique and or fluoroscopy based 
instrumentation[18,19]. 
Limitations 
Our study has some limitations. The size of the study population was 
small, and thus not well suited for statistical analysis, eg.; on various possible 
correlations. As a result of low numbers of patients we combined braced patients 
and observation patients in the same group for comparison with the surgical group. 
This comparison provides an overview of the variation of doses among the groups, 
but will not reflect very well what is the typical dose for braced patients 
specifically. 
Reducing dose 
There are several ways to achieve reduction of radiation exposure. The 
most simple way is  to reduce the number of x-rays and avoid CT scans, while 
optimizing radiological equipment is an continuously ongoing process. In fact, 
little might be gained from routine imaging unless the patient has unexpected 
symptoms, Garg et al[17] found that only 2.9 /1000 spine x-rays led to revision 
surgery. Thus, it may very likely be possible to lower the number of spine 
radiographs without affecting the quality of treatment. 
Conclusion 
The magnitude of cumulative radiation during scoliosis treatment varies 
substantially depending on radiographic follow-up protocol, intraoperative and 
ancillary imaging. Future studies are needed for highlighting the clinical 
consequences of lowered or elevated frequency of x-ray monitoring, founding the 
basis of future consensus guidelines on radiographic follow-up. By using low- 
dose x-ray systems such as EOS stereo-radiography in combination with low-dose 
protocol for intraoperative navigation it is possible to keep exposure to patients at 
a minimum balancing potential risks of adverse effects such as screw 
misplacement and radiation induced cancer, while still providing optimal care. 
One ancillary CT scan may double total cumulative full-body absorbed radiation 
dose. 
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Table 1 Demographics and Radiation exposure 
Treatment Conservative Surgery Both groups 
Patients  19 42 61 
Males  6 11 17 
Females  13 31 44 
Age at initial assessment* 15 (5-18) 14 (3-17) 14 years (3-18) 
Age at final assessment* 15 (9-19) 17 (14-20) 17 years (9-20) 
Time of follow-up* 9 months (0-52) 38 months (13-163)   
Cobb angle  (°) initial 
assessment* 
19 (10-50) 45 (10-80)  
Cobb angle (°) 
before surgery** 
 52 (36-82)  
Cobb angle  (°) final  
assessment* 
23 (12-65) 16 (4-30)  
Mean number of  
fused vertebrae 
 11  
Radiation exposure Conservative group1 
(Median and range) 
Surgery group 
(Median and range) 
Conventional spine  
X-rays (CR) number2 / 
radiation dose 
4 (0-20)/1.1mSv(0-5.5) 14.5 (2-57)/4.1mSv(0.6-15.5) 
Biplanar EOS imaging 
Number2 / radiation dose 
2 (0-17)/ 0.58mSv(0-2.4) 10.5 (0-26)/ 1.3mSv(0-3.1) 
O-arm 3d scans 
Number/ dose 
 
 2(1-4)/ 3.8mSv(0.9-10.0) 
O-arm 2D fluoroscopy 
time in seconds/ dose 
 33.7(20.3-136.0)/ 0.9mSv(0.4-3.5) 
Radiation dose combined 
(CR, EOS, O-arm)  
1.1mSv(0.2-7.2) 10.3mSv(3.8-20.4) 
Additional CT and  
PET-CT3 
0 1(1-2) 
Radiation dose 0 11.9mSv(0.6-20.1) 
 
 
Total radiation dose all 
modalities 
1.1mSv(0.2-7.2) 10.8mSv(3.8-35.9) 
*Median values and range 
**The Cobb angle just prior to surgery 
1Braced and observational 
2Total number of coronal and lateral images 
3A total of 6 patients had additional imaging owing to various reasons explained in the results section.  
1
0 
 
 
Table 2. The magnitude of radiation dose from ancillary CT and Pet-CT  
Patient id Modality Radiation dose Factor of increase 
in total radiation 
dose** 
Percentage of total 
radiation dose*** 
13 CT cervical spine 5.38 mSV 2.0  50%  
27 CT thoraco-lumbar 
spine* 
17.03 mSV 1.9 48% 
34 PET-CT full spine 
and CT lumbar spne* 
20.13mSV 3.1 67% 
38 CT lumbar spine 6.70 mSv 1.7 42% 
45 CT cervical spine 0.57 mSv 1.1 6% 
46 CT thoraco-lumbar 
spine* 
18.03 mSv 2.1 53% 
*MARS (metal artefact reducing software) technique  
** Total radiation (CR, EOS, O-arm and ancillary CT and Pet-CT)/ ancillary CT and PET-CT 
*** Ancillary radiation dose/total radiation dose from all modalities 
 
 
 
 
 
 
Table 3. Differences of radiographic systems used for scoliosis follow-up and 
intraoperatively. Number of centers using out of 8 spine centers.  
Conventional 
radiography 
1 Digital 
radiography 
3 EOS biplanar 
slotscanner 
2 EOS and 
Digital 
radiography 
1 
Freehand 
technique only 
 
5 
Fluoroscopy 
(C-arm) 
 
1 
O-arm 
intraoperative 
navigation 
 
1 
Postoperative 
CT scan 
routinely 
 
1 
 
1
1 
 
 
1
2 
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ABSTRACT
This study evaluated repeated mean organ dose measurements of the liver by phantom dosimetry 
and statistical modelling in order to find a way to reduce the number of dosemeters needed for 
precise organ dose measurements. Thermoluminescent dosemeters were used in an adult female 
phantom exposed to a biplanar x-ray source at three different axial phantom rotations. 
Generalized mixed linear effect modelling was used for statistical analysis. A subgroup of five to 
six organ specific locations out of 28 yielded mean liver organ doses within 95% confidence 
intervals of measurements based on all 28 liver specific dosemeter locations. No statistical 
difference of mean liver dose was observed with rotation of the phantom either 10° clockwise or 
counter-clockwise as opposed to the coronal plane. Phantom dosimetry handling time during 
organ dose measurements can be markedly reduced, in this case the liver, by 79% (22/28), while 
still providing precise mean organ dose measurements.
INTRODUCTION
Performing full-body radiation dose dosimetry in anthropomorphic phantoms is demanding and time 
consuming. Therefore, usually only a subset of available dosemeter positions within phantoms are used 
hoping that these will reflect mean absorbed radiation dose to the specific organs and the body as a 
whole. However, one cannot be sure that the chosen subset of positions used represent the “true” mean 
organ doses of the organs of interest. For instance, the liver, an organ of irregular symmetry, most often 
presents with numerous options for dosemeter allocations. In a typical anthropomorphic phantom, such 
as the ATOM female phantom(1) the liver holds 28 different liver dosemeter positions, picking only a 
few of these positions will result in thousands of different possible TLD placement combinations, many 
with statistically significant different mean doses as a consequence. If all 290 predefined organ specific 
thermoluminescent dosemeter (TLD) positions in this particular anthropomorphic phantom were to be 
used, according to own experience, it would most likely take in excess of 18 hours of continuous work 
effort to prepare dosemeters (annealing and calibration), instalment of dosemeters in the phantom, 
expose the phantom, remove dosemeters and measure dose exposure. This being for a single phantom 
with mean organ dose measurements and calculation of effective dose. As such, preparing phantoms 
and dosemeters for organ dose measurements is potentially a very time consuming and costly process. 
Thus, it is of great importance to investigate ways to reduce the number of TLDs needed to make 
consistent and precise dose monitoring. Then, the question is how the best and most precise 
measurements can be obtained by the least amount of effort?  This is a methodological study 
investigating the influence of different factors on mean absorbed organ dose (liver) and on the basis of 
this aiming to propose a method to determine the optimal placement and number of TLDs allowing for 
precise repeated and efficient monitoring of mean organ doses. Secondly, this study offered an 
opportunity to evaluate TLD (MCP-N) sensitivity changes over the course of repeated radiation cycles. 
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MATERIALS AND METHODS
Phantom
An adult female anthropomorphic ATOM phantom, 702-D, (CIRS- computerized imaging reference 
systems, INC. Virginia, USA)(1) was used to investigate liver organ radiation dose absorption (Figure 
1). The ATOM phantom has been designed for the purpose of investigating organ dose and image 
quality, it consists of tissue-equivalent epoxy resins. The phantom represents an adult female with a 
height of 165cm and a weight of 55 kg. The phantom consists of 38, 25mm thick, axial slices. Each 
slice holds a number of organ specific locations, each  location has a 5mm diameter hole containing a 
tissue specific cylindrical plug for TLD placement. Each TLD is placed in the middle of each of the 
vertical tissue-equivalent cylindrical plugs. The adult female phantom holds a total of 290 locations for 
TLD positioning, the liver holds 28 locations.  
Imaging system
For exposure of the phantom, the EOS low-dose slot scanning system (EOS imaging, Paris, France) 
(www.eos.imaging.com) was used. The EOS system provides two simultaneous full-body X-ray 
images, allowing for full body assessment in two planes (sagittal and coronal). In daily clinical practice 
at our institution the EOS system is used for routine evaluation of postural assessment in spine 
deformity patients. The EOS system has been described in detail previously (2). The system comes with 
different imaging protocols, the protocol used for phantom exposure in this study was the standard low-
dose setting shown in Table 1. 
Exposure and dose measurements
All 28 organ-specific dosemeter locations of the liver were utilized. The phantom was placed in the 
isocenter of the EOS scanner defined by the intersection of two orthogonal laser beams, custom fitted 
in the EOS. An isocenter of the phantom was marked corresponding to the intersection of the two 
perpendicular lines produced by the laser on phantom slice number 25 out of the 38 slices total. By 
adding overlying slices one at the time subsequent isocenters of each slice containing liver TLD 
locations were defined and marked. The cross-section of the laser lined up with the phantom isocenter  
provided very precise repositioning of the phantom between dose readings. From this position, with the 
same isocenter, three series of exposures were executed. Three different fixed positions of the phantom 
were chosen: Anteroposterior (AP), AP-10°(10 degrees of axial rotation counter-clock wise to the left 
side of the phantom) and AP+10° (10 degrees of axial rotation to the right side of the phantom). Figure 
2 shows the intersection of the laser beams on the defined isocenter of the phantom. For each of the 
above-mentioned three positions a series of seven scans were performed, each with a total of five 
consecutive standard-dose exposures followed by dose readings. This resulted in a total of 105 liver-
organ exposures and 21 dose measurements. The organ specific dose for each set of five exposure was 
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calculated by summing the dose measured for each internal dosimeter position, preceded by subtraction 
of mean ambient background dose (ad). The mean liver organ dose in µGy for one phantom exposure 
thus being: , where  is the dose at position i and  is the estimated mean  !"#$%=
1
28
∑
28
"= 1
'"― ')
5
'" ')
ambient background dose estimated from four non-exposed dosemeters calibrated at the same time as 
the dosemeters exposed within the liver.
For each of the 28 internal dosimeter location a specific TLD was allocated. Four TLDs were used for 
registration of accumulated background dose from the time of calibration to the time of dose readings 
after phantom exposure. The specific TLD for each position was annealed, calibrated and repositioned 
in the exact same position for each round of exposure and subsequent dose reading. This allowed for 
measuring intra-object dose readings for each tablet, for each internal positioning, for each of the three 
phantom positions. Furthermore, the same TLDs were annealed and calibrated systematically in the 
same order allowing for observations on variability with regard to  calibrated dosemeter reference dose 
readings after one exposure to a 90Sr source. Mean reference dose values for the 32 TLDs were 
registered prior to each of the 21 exposure cycles.  
MCP-N Dosemeter, Irradiator and Reader
For dose measurements MCP-N (Krakow, Poland) TLDs were used. The MCP-N is a solid Lithium-
fluoride dosemeter doped with magnesium, copper and phosphorus (LiF:Mg, Cu, P). It is a highly 
sensitive dosemeter with 30 times higher sensitivity to gamma ray doses than the MTS-N TLD, and is 
well-suited for low-dose measurements(3). 
The PTW Freiburg Annealing Oven (TLDO. PTW, Freiburg Germany) was used for annealing of the 
dosemeters. The TLDs were annealed using a specific time temperature profile (TTP) heating the 
dosemeters to 240 degrees Celsius for a time period of 15 minutes. After annealing the TLDs were 
calibrated using the Rados IR-2000 - 90Sr Irradiator (RadPro International GmbH, Wermelskirchen, 
Germany). The IR-2000 of this study held a 90Sr source of approximately 0.290 mGy, which was used 
to provide background dose to the dosemeters. Each TLD received one background dose exposure 
during calibration. The Rados RE-2000 reader (RadPro International GmbH, Wermelskirchen, 
Germany) was used for dose readings. 
Statistical and data analyses
Statistical analyses on relationship between dose absorption, TLD location and phantom rotation was 
performed, relaying information on liver organ doses and variability. Mean organ doses for each 
phantom position was calculated and uncertainty doses expressed within 95% confidence intervals. In 
order to evaluate the effect of rotation of the phantom with regard to x-ray sources and the relayed 
effect on the individual location of the TLDs, generalized mixed effect linear modelling(4),(5) using R 
(R-Project for Statistical Computing, version 3.6.1) was performed, when nothing else is mentioned R 
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Base was used. Subsequently, an investigation into whether a subset (reduced number) of TLDs could 
relay precise information of total mean organ dose was undertaken:
Photos and coordinate calculations 
Digital images of each of the 7 slices holding liver positions were photographed with a high resolution 
digital camera, Figure 3. The camera position was the same for all images – same distance to the slice 
and the camera was positioned at a zero degree angle (parallel) to the phantom slice. Two key distances 
were measured on each of the slices corresponding to the length of the 2 perpendicular lines drawn on 
the phantom slices through the isocenter from front to back and from left to right. The coordinates for 
each of the TLD positions were calculated from the digital images, the known line lengths of the 2 lines 
mentioned above and the line placement as seen on the digital images using the R package Digitize(6) 
and the function digitize. The rotated positions were calculated with the formulas x’ = x cos(θ) + y 
sin(θ), y’ = y cos(θ) - x sin(θ), where θ is the angle of rotation and x’ and y’ the coordinates after 
rotation.
Generalized Mixed Linear Effects Model analysis 
Due to the hierarchical nature of the data a generalized mixed linear effects model was used to analyse 
the data with the count variable as the dependent variable and the independent variables x-coordinate, 
y-coordinate, difference in x-coordinate by rotation, difference in y-coordinate by rotation, the angle of 
rotation (factor), slice number (factor) and the random factor 1 + replicate number | TLD position. 
Replicate number refers to the 7 consecutive series of exposures and subsequent measurements. The 
formula can simplified be written as:
Count ~ β0 + β1*X-coordinate + β2 * Y-coordinate + β3 *difference in X-coordinate + β4 * difference in 
Y-coordinate + β5 * Rotation-factor + β6 * Slice factor + β7 * Replicate-factor + β8 * (1 + Replicate-
factor | TLD position)
Where β zero to eight represent the regression coefficients, Table 2. We chose not to include any 
interaction terms in the analysis as the meaning of such terms would be difficult to interpret and 
complicate the model. The R package lme4 and the function glmer.nb(7) and anova function and the 
change in Akaike Information Criteria (AIC) was used for the generalized mixed linear effects model 
analysis. Model assumptions were checked by plotting the Pearson residuals against predicted values 
and by plotting the standardized residuals against predicted values and by plotting the standardized 
residuals against leverage. Collinearity was evaluated with the Variable Inflation Factor (VIF).
Subset analysis
The aim was to determine the best possible subset of TLD positions giving approximately the same 
estimate of the dose as the full set of TLD’s (28 positions). We chose to use subsets of 1 to 8 tablets or 
TLD positions. The subsets were generated using the R package gRbase(8) and the function combnPrim. 
The average and standard deviations for the full dataset were calculated (base R) and compared to the 
absorbed dose for the subset of 1 to 8 tablets or TLD positions using only the observations in the 
specific subset. The difference to the estimate based on the full set of tablets or TLD positions was 
calculated.  The subsets were sorted according to their signed deviation from zero (concordant 
estimates of the subset estimate and full set estimate) and  plotted against the difference to the estimate 
based on  the full data set. The total number of different subsets for each of the 1 to 8 subsets were 
calculated and the number of acceptable subsets were calculated (deviations from zero not significant, 
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95% confidence limits). Lastly, based on the physics of radiation and the architecture of the EOS 
scanner we pointed out what we thought would be the most optimal choice of TLD positions (the way 
we think other researchers might have done to minimize the time used to do the measurements), subsets 
of three to six TLDs were compared to the estimates based on the full dataset. 
RESULTS
The TLD positions are plotted in Figure 4, numbered and colour coded according to position and 
rotation. Besides the colour coding the rotation is also indicated by the suffix A, B or C. This was 
illustrated by using the R package ggplot (9).
Mean organ doses for the three exposure positions are shown in Figure 5. A trend towards differences 
of mean organ doses with clockwise or anti-clockwise rotation was found, but regardless of rotation, no 
statistically significant differences were observed. The generalized mixed linear effects model is 
summarized in table 2. The slice factor variable did not add anything to the model. Only the intercept 
of the random factor replicate number was part of the model. All other variables mentioned earlier was 
in the model (see formula). Model validation indicated no problems. All VIF’s were below 4.
Subset analysis
Figure 6, shows the result of all possible combinations of 1-8 TLDs and the dispersion around the mean 
organ dose based on all 28 TLDs.
Table 3 illustrates the relationship between number of TLDs in a subset and number of acceptable 
combinations of TLDs yielding mean organ dose within the 95% CI of the “true” mean dose from all 
28 dosemeter locations. Table 4 shows the four combinations of 3-6 TLD positions reaching values 
closest to the “true” mean based on the subset analysis. A list of combinations from 1-8 TLDs reaching 
up to ten best combinations of TLDs can be found in appendix 1.
Table 5 shows the subsets (empirically chosen) and subsequent mean liver dose values, for comparison 
with table 4, values within 95% CI of true mean dose are marked in bold. In the subset of three TLDs, 
six in twelve had a mean dose within the 95% CI of the “true” mean organ.. For the subset of four 
TLDs it was seven in twelve, in   the subset of five TLDs twelve out of twelve had a value within the 
95% CI of each specific rotation of the phantom. The subset of six TLDs resulted in eleven out of 
twelve with a mean dose within the 95% CI.
TLD sensitivity changes
A total of 672 reference dose measurements were performed for the 28 position specific TLDs and the 
four TLDs used for registration of background dose. Figure 7 shows the mean reference dose for all 32 
TLDs measured over the course of the 21 radiation cycles, illustrating a downwards trend. The mean 
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reference dose value at initial measurements was 231078 counts +/-2SD (211,531-250,625) vs 206187 
counts +/-2SD (182,997-229,377) at final measurements. An almost 10% difference, but no statistically 
significant difference. We did not observe the same trend of decreased measures of radiation dose for 
the three rotational positions where all measurements were calibrated against the new specific reference 
dose measurements. This is illustrated in Figure 6 where liver doses were also compared to previously 
published values by the same authors(10). No significant variation in dose reading was observed for any 
of the TLD tablets. 
DISCUSSSION
The primary aim of this study was to analyse doses absorbed in different rotations of an 
anthropomorphic phantom holding 28 liver specific TLD locations, and to investigate a way to 
extrapolate information in order to reduce the number of TLDs needed for the use of estimating precise 
mean organ doses within the human body. In the subset analysis of 1-8 TLDs, all possible 
combinations were investigated as shown in Table 3 and Figure 5, and proved the validity of our 
method. In combination the latter two show the number of  possible combinations and the number of 
”acceptable” combinations, and illustrate that no unanticipated deviations occurred. The 
mathematically generated subsets of 3-6 TLDs of Table 4 are as anticipated much more precise than the 
empirically chosen subsets of Table 5. However, the subsets of 4-6 were very likely to yield mean liver 
doses within the 95 confidence interval of the “true” liver dose based on the 28 TLD locations. In fact, 
35 out of 36 mean doses were within these boundaries. Thus, by either calculating best fits for subsets 
of 1-8 TLDs based on measured radiation dose from all available measuring points, or by 
symmetrically choosing subsets of 5-6 TLDs around the isocenter of the phantom and in relation to x-
ray sources, mean doses within 95% CI of “true” mean dose could be achieved. This indicates that a 
reduced number of  TLDs can provide an acceptable approximation of true organ dose. One option 
being the calculation of best fits from all 28 measuring points to elect specific subset, another option, 
however not as precise would be the more simple approach of logical selection of positions as shown 
above. As a result, handling time during organ dose measurements can be markedly reduced, in this 
case the liver, by at least 79% (22/28), while still providing precise mean organ dose measures.
Secondly, this study evaluated the effect of minor movement that could imitate unintended movement 
of the patient or alterations in patient positioning during radiographic exposure, on the absorbed 
radiation dose of the liver in an anthropomorphic phantom. No statistically significant change of mean 
absorbed dose to the liver regardless of clockwise or anti-clockwise phantom rotation of 10° was 
found. This implies that minor movement of a patient within the scene of x-ray exposure will not affect 
absorbed radiation dose much. 
TLD reference dose readings over time showed an apparent sensitivity loss after repeated cycles of 
annealing and dose reading. In fact, a trend towards a reduced sensitivity of almost 11% after 21 
radiation cycles was observed. This was similar to the findings of Poirier et al 2018(11) who experienced 
a drop of approximately 20% over 44 cycles. What is the exact cause of this reduction of sensitivity is 
not clear. Lüpke et al (RPD)2006(12), found that TLD sensitivity could be altered significantly if 
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annealing temperatures for MCP tablets exceeded 240 degrees, they observed a drop in sensitivity of 
0.45% per cycle. Differences in cooling rates have also been found to influence sensitivity of 
dosemeters (13), however all dosemeters of this study were cooled at the same speed for each cycle. 
Fernandez et al 2016(14) found that low-intensity traps were cleared insufficiently causing a residual 
signal. However, this would result in a higher dose reading and not lower as experienced in our study, 
likewise during dose-readings we custom-made a 5 second delay to allow for release of low-intensity 
traps. We do not consider the impact of decay from the 90Sr source to be of significance in this study. 
The half-life of the 90Sr source is 28.8 years, and measurements were made over a time period of 64 
days, resulting in a 0.43% reduction of the source activity (1-exp(-(ln(2)/28.8 years)0.18 years)). The 
findings of reduced sensitivity of the TLDs over time emphasizes the importance of careful calibration 
of TLDs over time. Mixing of dosemeters from different batches after diverging number of cycles/ 
radiation history should be avoided, in order to keep heterogeneity at a minimum. 
The findings of the generalized mixed linear effects model analysis correlated well with what we would 
expect. The coordinates of the TLD position were a significant factor which is in accordance with the 
laws of physics especially the inverse square law. The differences in the x- and y-coordinates with 
rotation were significant factors in our model which we would also expect for the same reason as 
mentioned above. However, the angle of rotation (as factor) was also a significant factor. As a 
consequence of geometrical relations the distance of the radiation beam through tissue will increase for 
some TLDs and for others this distance will decrease, or be almost the same depending on the amount 
of rotation and the position . With axial phantom rotation the amount and type of “tissue” that the 
radiation beam must pass will also change, so the effect of rotation cannot be described entirely with 
the change in coordinates. It did not matter to which slice the TLDs belonged.  The y-axis intercept for 
the TLDs did vary significantly but we did not find any random effect over time for the calibrated 
TLDs (measurements 1-21) - since the same TLD was repositioned in the same location within the 
phantom during all scans. 
Limitations
The study was as most organ dose studies limited by the fact that organ dose measurements were 
estimated based on in vitro phantom dosimetry and not direct in vivo measurements. However, it is the 
belief of the authors that in-phantom dosimetry in anthropomorphic phantoms is equivalent to or better 
than PCXMC(15) mathematical phantom organ dose estimations. In-phantom dosimetry is as close as 
one gets to real life in vivo measurements. The above-mentioned reduced sensitivity of TLDs after 
repeated cycles of radiation is a limiting factor if not careful calibration is performed after each cycle, 
of TLD sensitivity against the radiation reference source, in this case the 90Sr source.
The accuracy of the digitize R package has been evaluated by Poisot et al, 2011(6). The accuracy was 
deemed acceptable and the package was not difficult to apply. In this case the TLDs were somewhat 
bigger than the points in most scatterplots making it possible to vary how you mark the TLD positions 
on the phantom slices. However, we do not consider this to be of any importance as these differences 
were only observed in the second decimal when repeating the measurements. 
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The estimation of liver organ dose from the empirically selected subset of TLDs were few and only one 
person performed the selection of TLD positions. And it could be argued that a larger number of 
empirically chosen subsets should have been evaluated. However, the trend was very clear with almost 
100% of mean doses within the 95% CI of measured liver doses when choosing five or six TLD 
positions in a logical symmetrical fashion. 
CONCLUSIONS
Through phantom dosimetry and a combination of generalized mixed effect analysis and subset 
analysis we have constructed a model proposing a reduced number of TLD locations that can be relied 
upon when estimating liver mean organ dose. In the current study five or six locations versus 28 
possible locations for TLD placement offered a mean organ dose not statistically significantly different 
from the mean dose using all 28 TLD organ specific locations. Axial rotation of the phantom either 
clockwise or anti-clockwise with regard to x-ray source, mimicking patient movement or inter-operator 
alterations in patient positioning, did not have a significant impact on mean organ dose. 
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Figure 1. A female adult phantom 
(ATOM model 702-D, CIRS). 
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Figure 2. Phantom slice with orthogonal laser positioning marking. (A) 10° of counter-clockwise axial 
rotation of phantom. (B) Neutral Anteroposterior (AP) positioning of phantom. 
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Figure 3. Example of phantom slice holding liver positions. 
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Figure 4. The TLD positions within the phantom, colour coded according to position and axial rotation of the 
phantom. Besides the colour coding the rotation is also indicated by the suffix A, B or C. 
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Figure 5. The variation (rank) of deviation from the mean dose from all 28 TLDs, calculated from subsets of 
1-8 Tabs.(TLD positions). 
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Figure 6. Radiation doses for the three axial rotational positions as well as liver doses previously measured 
and published by same authors(10). 
493x282mm (72 x 72 DPI) 
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Figure 7. The mean reference dose for all 32 TLDs over the course of the 21 radiation cycles. 
(28 liver positions, and the four TLDs used to measure background dose) 
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Table 1. EOS imaging parameters. 
Standard-dose protocol used for a single biplanar full-spine scan of an adult female phantom
Anteroposterior exposure Lateral exposure
Morphotype Medium Medium
Scan speed 4 4
Scan time seconds 12.5 12.5
Tube potential (kV) 90 105
Tube Current (mA) 250 250
Filtration 1.5mm AL+0.1mm Cu 1.5mm AL+0.1mm Cu
Scan Height 95 cm 95 cm
Distance source-to-isocenter 987mm 918mm
Distance source-to-detector 1300mm 1300mm
Dose-area product (mGy x cm2) 436.6 648.0
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Table 2. Estimated regression parameters, standard errors, z-values and p-values for the final negative binomial 
generalized mixed linear effect model.
Variable Estimate Std.error Z-value p-value
Intercept 19.618 0.042 471.232 0.000
X-coordinate -0.063 0.004 -14.013 0.000
Y-coordinate -0.087 0.004 -19.623 0.000
X-coordinate difference -0.019 0.008 -2.508 0.012
Y-coordinate difference -0.037 0.005 -7.852 0.000
Rotation minus 10 degr. 0.068 0.009 7.725 0.000
Rotation plus 10 degr. -0.013 0.009 -1.514 0.130
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Table 3. The number of TLDs in a subset in relation to possible combinations and acceptable combinations 
yielding a “true” mean dose.
No. TLDs Combinations Acceptable combinations 1/Ratioa
1 28 2 0.071
2 378 25 0.066
3 3276 314 0.096
4 20475 2240 0.109
5 98280 11486 0.117
6 376740 46218 0.123
7 1184040 151884 0.128
8 3108105 413259 0.133
aThe probability of an acceptable combination 
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Appendix I, Study V 
 
 
 No. TLDs TLD positions within phantom* Difference [mSv] (9 decimal 
precision) 
P-value 
1 134 -0.01752381 0.18447 
1 140 -0.035666667 0.07835 
2 133,135 -0.000880952 0.93666 
2 121,142 -0.000952381 0.99471 
2 138,160 0.004619048 0.63268 
2 122,135 0.00497619 0.66299 
2 119,136 0.006119048 0.53228 
2 136,138 -0.006666667 0.56817 
2 139,140 0.00847619 0.55396 
2 140,174 0.012047619 0.37574 
2 122,125 -0.016880952 0.17556 
2 134,139 0.017547619 0.16183 
3 123,139,174 -0.000142857 0.9867 
3 134,139,140 -0.000190476 0.98874 
3 119,140,160 -0.000285714 0.97264 
3 121,140,176 0.000285714 0.99697 
3 123,138,141 -0.000285714 0.97064 
3 122,133,142 0.000380952 0.96348 
3 119,139,142 -0.00052381 0.93598 
3 121,135,175 -0.000952381 0.99057 
3 123,138,187 0.001190476 0.87052 
3 132,135,187 -0.001666667 0.89695 
4 121,123,139,176 0.00002381 0.99964 
4 119,140,141,159 -0.00002381 0.99754 
4 133,138,140,143 -0.00002381 0.99826 
4 120,122,159,175 0.000047619 0.99224 
4 125,132,139,141 -0.000130952 0.99168 
4 118,139,160,161 -0.000130952 0.98775 
4 132,159,174,176 -0.000130952 0.99084 
4 119,120,139,161 -0.000238095 0.96795 
4 119,122,125,160 0.000261905 0.97344 
4 118,124,125,161 -0.00027381 0.97344 
4 124,134,138,187 -0.00027381 0.97432 
5 121,123,124,159,175 -0.000002381 0.99995 
5 121,133,134,141,142 0.000004762 0.99991 
5 123,131,134,135,143 -0.000009524 0.99927 
5 122,124,138,139,143 -0.000009524 0.99902 
5 119,123,124,174,175 -0.000009524 0.99858 
5 125,131,136,139,187 -0.000009524 0.99934 
5 119,122,141,158,176 -0.000009524 0.99908 
5 121,133,135,161,174 -0.000016667 0.99967 
5 131,134,142,143,158 0.000019048 0.99883 
5 123,131,133,142,161 0.000019048 0.9986 
6 131,133,136,139,176,187 0 1 
6 119,124,135,139,158,175 0 1 
6 119,124,139,140,158,176 0 1 
6 121,124,132,136,141,175 0 1 
6 121,132,140,141,142,175 0 1 
6 133,138,158,159,160,175 0 1 
 
 
 
6 119,123,125,131,160,161 0 1 
6 119,132,139,159,161,187 0 1 
6 125,131,132,136,175,176 0 1 
6 124,131,133,159,160,161 0 1 
7 119,121,122,134,136,141,17
6 
0 1 
7 119,121,122,125,136,143,17
4 
0.000003401 0.9999 
7 119,121,122,124,135,141,16
1 
-0.000003401 0.9999 
7 121,138,139,142,158,159,16
1 
-0.000003401 0.99989 
7 119,121,125,138,140,143,17
6 
-0.000003401 0.99989 
7 119,120,122,134,135,139,14
3 
0.000006803 0.99903 
7 121,124,138,140,141,142,15
9 
0.000006803 0.99978 
7 119,123,131,133,160,161,17
6 
0.000006803 0.99931 
7 120,122,123,134,135,139,15
9 
0.000006803 0.99889 
7 122,123,124,132,138,143,16
0 
0.000006803 0.99933 
7 124,132,133,134,136,158,16
0 
0.000006803 0.99951 
7 123,125,131,134,136,158,17
5 
0.000006803 0.99951 
7 124,125,131,133,134,141,17
6 
0.000006803 0.99949 
8 121,122,132,134,136,139,14
2,176 
-0.00000085 0.99996 
8 121,123,132,134,136,140,16
1,174 
-0.00000085 0.99996 
8 121,123,133,138,139,142,16
0,175 
-0.00000085 0.99997 
8 119,121,124,138,142,143,17
4,175 
-0.00000085 0.99997 
8 119,121,122,135,140,159,16
0,176 
-0.00000085 0.99997 
8 119,121,138,139,140,141,16
1,176 
-0.00000085 0.99997 
8 121,132,133,136,159,160,17
4,176 
-0.00000085 0.99996 
8 121,133,138,139,142,159,16
0,187 
-0.00000085 0.99997 
8 121,134,138,142,158,160,17
4,175 
0.000001701 0.99993 
8 118,121,124,134,135,136,17
5,176 
0.000001701 0.99993 
8 119,120,121,125,132,161,17
5,176 
0.000001701 0.99994 
8 119,121,131,139,142,143,16
1,187 
0.000001701 0.99993 
*Adult female anthropomorphic ATOM phantom, 702-D, (CIRS- computerized imaging 
 reference systems, INC. Virginia, USA) 
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